BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rice TW, Rusch VW, Ishwaran H, Blackstone EH; Worldwide Esophageal Cancer Collaboration. Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals. Cancer. 2010;116:3763-3773. [PMID: 20564099 DOI: 10.1002/cncr.25146] [Cited by in Crossref: 301] [Cited by in F6Publishing: 308] [Article Influence: 25.1] [Reference Citation Analysis]
Number Citing Articles
1 Feng JF, Chen S, Yang X. Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus. Medicine (Baltimore) 2017;96:e5886. [PMID: 28121932 DOI: 10.1097/MD.0000000000005886] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
2 Abe T, Hosoi T, Kawai R, Uemura N, Higaki E, An B, Kawakami J, Saito T, Shimizu Y. Perioperative enteral supplementation with glutamine, fiber, and oligosaccharide reduces early postoperative surgical stress following esophagectomy for esophageal cancer. Esophagus 2019;16:63-70. [PMID: 30030739 DOI: 10.1007/s10388-018-0630-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Celik S, Erten R, Batur A, Suvak B. A Dilemma in Staging of Esophageal Cancer: How Should We Stage ypT0 N2 M0 Esophageal Cancer after Neoadjuvant Therapy? Case Rep Pathol 2015;2015:158626. [PMID: 26346409 DOI: 10.1155/2015/158626] [Reference Citation Analysis]
4 Liu X, Wu L, Zhang D, Lin P, Long H, Zhang L, Ma G. Prognostic impact of lymph node metastasis along the left gastric artery in esophageal squamous cell carcinoma. J Cardiothorac Surg 2021;16:124. [PMID: 33941213 DOI: 10.1186/s13019-021-01466-2] [Reference Citation Analysis]
5 O'Neal RL, Nam KT, LaFleur BJ, Barlow B, Nozaki K, Lee HJ, Kim WH, Yang HK, Shi C, Maitra A, Montgomery E, Washington MK, El Rifai W, Drapkin RI, Goldenring JR. Human epididymis protein 4 is up-regulated in gastric and pancreatic adenocarcinomas. Hum Pathol 2013;44:734-42. [PMID: 23084584 DOI: 10.1016/j.humpath.2012.07.017] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
6 Jomrich G, Paireder M, Gleiss A, Kristo I, Harpain L, Schoppmann SF. Comparison of Inflammation-Based Prognostic Scores in a Cohort of Patients with Resectable Esophageal Cancer. Gastroenterol Res Pract 2017;2017:1678584. [PMID: 28740506 DOI: 10.1155/2017/1678584] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
7 Shapiro J, van Klaveren D, Lagarde SM, Toxopeus ELA, van der Gaast A, Hulshof MCCM, Wijnhoven BPL, van Berge Henegouwen MI, Steyerberg EW, van Lanschot JJB. Prediction of survival in patients with oesophageal or junctional cancer receiving neoadjuvant chemoradiotherapy and surgery. British Journal of Surgery 2016;103:1039-47. [DOI: 10.1002/bjs.10142] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
8 Yamada I, Hikishima K, Miyasaka N, Tokairin Y, Ito E, Kawano T, Kobayashi D, Eishi Y, Okano H. Esophageal carcinoma: Evaluation with q-space diffusion-weighted MR imaging ex vivo: q-Space Imaging of Esophageal Carcinoma. Magn Reson Med 2015;73:2262-73. [DOI: 10.1002/mrm.25334] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
9 Daiko H, Kato K. Updates in the 8th edition of the TNM staging system for esophagus and esophagogastric junction cancer. Jpn J Clin Oncol 2020;50:847-51. [PMID: 32519741 DOI: 10.1093/jjco/hyaa082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 Suh YS, Han DS, Kong SH, Lee HJ, Kim YT, Kim WH, Lee KU, Yang HK. Should adenocarcinoma of the esophagogastric junction be classified as esophageal cancer? A comparative analysis according to the seventh AJCC TNM classification. Ann Surg. 2012;255:908-915. [PMID: 22504190 DOI: 10.1097/sla.0b013e31824beb95] [Cited by in Crossref: 68] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
11 Rusch VW. The Thoracic Surgery Service at Memorial Sloan Kettering Cancer Center. Semin Thorac Cardiovasc Surg 2015;27:403-9. [PMID: 26811048 DOI: 10.1053/j.semtcvs.2015.10.004] [Reference Citation Analysis]
12 Jayaprakasam VS, Yeh R, Ku GY, Petkovska I, Fuqua JL 3rd, Gollub M, Paroder V. Role of Imaging in Esophageal Cancer Management in 2020: Update for Radiologists. AJR Am J Roentgenol 2020;215:1072-84. [PMID: 32901568 DOI: 10.2214/AJR.20.22791] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kim JH, Han KD, Lee JK, Kim HS, Cha JM, Park S, Kim JS, Kim WH; Big Data Research Group (BDRG) of the Korean Society of Gastroenterology (KSG). Association between the National Cancer Screening Programme (NSCP) for gastric cancer and oesophageal cancer mortality. Br J Cancer 2020;123:480-6. [PMID: 32398860 DOI: 10.1038/s41416-020-0883-x] [Reference Citation Analysis]
14 Atay SM, Correa A, Hofstetter WL, Swisher SG, Ajani J, Altorki NK, Blackmon SH, Blackstone EH, Rice TW, Crabtree TD, D'amico TA, Darling GE, Demeester SR, Demeester TR, Worrell SG, Ferri LE, Gaissert HA, Krasna MJ, Lerut A, Nafteux P, Moons J, Little AG, Low DE, Carrott PW, Schmidt HM, Miller D, Nason KS, Luketich JD, Orringer MB, Chang AC, Rizk NP, Salo JA, Schneider PM, Smithers BM, Vallböhmer D, van Lanschot J, Varghese TK, Watson TJ, Peters JH, Yang SC. Predictors of staging accuracy, pathologic nodal involvement, and overall survival for cT2N0 carcinoma of the esophagus. The Journal of Thoracic and Cardiovascular Surgery 2019;157:1264-1272.e6. [DOI: 10.1016/j.jtcvs.2018.10.057] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
15 Irino T, Takeuchi H, Matsuda S, Saikawa Y, Kawakubo H, Wada N, Takahashi T, Nakamura R, Fukuda K, Omori T, Kitagawa Y. CC-Chemokine receptor CCR7: a key molecule for lymph node metastasis in esophageal squamous cell carcinoma. BMC Cancer 2014;14:291. [PMID: 24766770 DOI: 10.1186/1471-2407-14-291] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
16 Ku JW, Zhang DY, Song X, Li XM, Zhao XK, Lv S, Hu SJ, Cheng R, Zhou FY, Wu HF, Wang LD. Characterization of tissue chromogranin A (CgA) immunostaining and clinicohistopathological changes for the 125 Chinese patients with primary small cell carcinoma of the esophagus.Dis Esophagus. 2017;30:1-7. [PMID: 28575250 DOI: 10.1093/dote/dox041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
17 Wani S, Drahos J, Cook MB, Rastogi A, Bansal A, Yen R, Sharma P, Das A. Comparison of endoscopic therapies and surgical resection in patients with early esophageal cancer: a population-based study. Gastrointest Endosc. 2014;79:224-232.e1. [PMID: 24060519 DOI: 10.1016/j.gie.2013.08.002] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 7.6] [Reference Citation Analysis]
18 Duan X, Shang X, Yue J, Ma Z, Chen C, Tang P, Jiang H, Yu Z. A nomogram to predict lymph node metastasis risk for early esophageal squamous cell carcinoma. BMC Cancer 2021;21:431. [PMID: 33879102 DOI: 10.1186/s12885-021-08077-z] [Reference Citation Analysis]
19 Ruffato A, Mattioli S, Perrone O, Lugaresi M, Di Simone MP, D'errico A, Malvi D, Aprile MR, Raulli G, Frassineti L. Esophagogastric Metaplasia Relates to Nodal Metastases in Adenocarcinoma of Esophagus and Cardia. The Annals of Thoracic Surgery 2013;95:1147-53. [DOI: 10.1016/j.athoracsur.2012.12.040] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
20 Yoon HH, Shi Q, Sukov WR, Lewis MA, Sattler CA, Wiktor AE, Wu TT, Diasio RB, Jenkins RB, Sinicrope FA. Adverse prognostic impact of intratumor heterogeneous HER2 gene amplification in patients with esophageal adenocarcinoma. J Clin Oncol 2012;30:3932-8. [PMID: 22987085 DOI: 10.1200/JCO.2012.43.1890] [Cited by in Crossref: 66] [Cited by in F6Publishing: 30] [Article Influence: 6.6] [Reference Citation Analysis]
21 Wittekind C. TNM 2010: Was ist neu? Pathologe 2010;31:153-60. [DOI: 10.1007/s00292-010-1341-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
22 Rice TW, Blackstone EH. Lymph node ratio: a confounded quotient. Ann Thorac Surg 2013;96:744. [PMID: 23910136 DOI: 10.1016/j.athoracsur.2013.03.102] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
23 Feng JF, Wang L, Jiang YH, Yang X. C-Reactive Protein to Prealbumin Ratio (CPR): A Novel Inflammatory-Nutritional Prognostic Factor for Predicting Cancer-Specific Survival (CSS) and Overall Survival (OS) in Patients with Resectable Esophageal Squamous Cell Carcinoma. J Oncol 2019;2019:4359103. [PMID: 31379941 DOI: 10.1155/2019/4359103] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
24 Xie X, Zhang S, Wen J, Yang H, Luo K, Yang F, Hu Y, Fu J. Protein kinase D1 mRNA level may predict cancer-specific survival in heavy smokers with esophageal squamous cell cancers: PRKD1 expression and ESCC outcomes. Dis Esophagus 2014;27:188-95. [DOI: 10.1111/dote.12077] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
25 Feng JF, Huang Y, Liu JS. Combination of neutrophil lymphocyte ratio and platelet lymphocyte ratio is a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma. Onco Targets Ther. 2013;6:1605-1612. [PMID: 24403837 DOI: 10.2147/ott.s52501] [Cited by in Crossref: 11] [Cited by in F6Publishing: 39] [Article Influence: 1.2] [Reference Citation Analysis]
26 Kim A, Ashman P, Ward-Peterson M, Lozano JM, Barengo NC. Racial disparities in cancer-related survival in patients with squamous cell carcinoma of the esophagus in the US between 1973 and 2013. PLoS One 2017;12:e0183782. [PMID: 28832659 DOI: 10.1371/journal.pone.0183782] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
27 Goodman KA. Esophagogastric junction carcinoma: introduction. Semin Radiat Oncol 2013;23:1-2. [PMID: 23207040 DOI: 10.1016/j.semradonc.2012.09.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Rice TW, Ishwaran H, Hofstetter WL, Kelsen DP, Apperson-Hansen C, Blackstone EH; Worldwide Esophageal Cancer Collaboration Investigators. Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus. 2016;29:897-905. [PMID: 27905172 DOI: 10.1111/dote.12533] [Cited by in Crossref: 57] [Cited by in F6Publishing: 68] [Article Influence: 11.4] [Reference Citation Analysis]
29 Yamada I, Miyasaka N, Hikishima K, Tokairin Y, Kawano T, Ito E, Kobayashi D, Eishi Y, Okano H. Ultra-high-resolution MR imaging of esophageal carcinoma at ultra-high field strength (7.0T) ex vivo: correlation with histopathologic findings. Magnetic Resonance Imaging 2015;33:413-9. [DOI: 10.1016/j.mri.2014.11.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
30 Ruffato A, Lugaresi M, Mattioli B, Di Simone MP, Peloni A, Daddi N, Montanari A, Anderlucci L, Mattioli S. Total Lymphadenectomy and Nodes-Based Prognostic Factors in Surgical Intervention for Esophageal Adenocarcinoma. The Annals of Thoracic Surgery 2016;101:1915-20. [DOI: 10.1016/j.athoracsur.2015.12.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
31 Rusch VW, Giroux DJ. Nodal staging in lung cancer: lymph node location or number? J Thorac Oncol 2011;6:237-8. [PMID: 21252713 DOI: 10.1097/JTO.0b013e318207f79e] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
32 Dikken JL, Coit DG, Klimstra DS, Rizk NP, van Grieken N, Ilson D, Tang LH. Prospective impact of tumor grade assessment in biopsies on tumor stage and prognostic grouping in gastroesophageal adenocarcinoma: Relevance of the seventh edition American Joint Committee on Cancer Staging Manual revision. Cancer 2012;118:349-57. [DOI: 10.1002/cncr.26301] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
33 Ji A, Jin R, Zhang R, Li H. Primary small cell carcinoma of the esophagus: progression in the last decade. Ann Transl Med 2020;8:502. [PMID: 32395546 DOI: 10.21037/atm.2020.03.214] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Zhu S, Wei Y, Gao F, Li L, Liu Y, Huang Z, Tang H, Zheng D, Wei X, Sun T, Song B. Esophageal carcinoma: Intravoxel incoherent motion diffusion-weighted MRI parameters and histopathological correlations. J Magn Reson Imaging 2019;49:253-61. [PMID: 29734492 DOI: 10.1002/jmri.26172] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
35 Yamada I, Hikishima K, Miyasaka N, Tokairin Y, Kawano T, Ito E, Kobayashi D, Eishi Y, Okano H, Shibuya H. Diffusion-tensor MRI and tractography of the esophageal wall ex vivo: Diffusion-Tensor MRI of Esophageal Wall. J Magn Reson Imaging 2014;40:567-76. [DOI: 10.1002/jmri.24411] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
36 Betancourt Cuellar SL, Sabloff B, Carter BW, Benveniste MF, Correa AM, Maru DM, Ajani JA, Erasmus JJ, Hofstetter WL. Early clinical esophageal adenocarcinoma (cT1): Utility of CT in regional nodal metastasis detection and can the clinical accuracy be improved? Eur J Radiol 2017;88:56-60. [PMID: 28189209 DOI: 10.1016/j.ejrad.2017.01.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
37 D’Journo XB, Thomas PA. Current management of esophageal cancer. J Thorac Dis. 2014;6 Suppl 2:S253-S264. [PMID: 24868443 DOI: 10.3978/j.issn.2072-1439.2014.04.16] [Cited by in F6Publishing: 52] [Reference Citation Analysis]
38 Yodying H, Matsuda A, Miyashita M, Matsumoto S, Sakurazawa N, Yamada M, Uchida E. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis. Ann Surg Oncol 2016;23:646-54. [DOI: 10.1245/s10434-015-4869-5] [Cited by in Crossref: 164] [Cited by in F6Publishing: 176] [Article Influence: 23.4] [Reference Citation Analysis]
39 Mokdad AA, Yopp AC, Polanco PM, Mansour JC, Reznik SI, Heitjan DF, Choti MA, Minter RR, Wang SC, Porembka MR. Adjuvant Chemotherapy vs Postoperative Observation Following Preoperative Chemoradiotherapy and Resection in Gastroesophageal Cancer: A Propensity Score-Matched Analysis. JAMA Oncol 2018;4:31-8. [PMID: 28975352 DOI: 10.1001/jamaoncol.2017.2805] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 10.0] [Reference Citation Analysis]
40 Rice TW, Chen LQ, Hofstetter WL, Smithers BM, Rusch VW, Wijnhoven BP, Chen KL, Davies AR, D'Journo XB, Kesler KA, Luketich JD, Ferguson MK, Räsänen JV, van Hillegersberg R, Fang W, Durand L, Cecconello I, Allum WH, Cerfolio RJ, Pera M, Griffin SM, Burger R, Liu JF, Allen MS, Law S, Watson TJ, Darling GE, Scott WJ, Duranceau A, Denlinger CE, Schipper PH, Lerut TE, Orringer MB, Ishwaran H, Apperson-Hansen C, DiPaola LM, Semple ME, Blackstone EH. Worldwide Esophageal Cancer Collaboration: pathologic staging data. Dis Esophagus 2016;29:724-33. [PMID: 27731547 DOI: 10.1111/dote.12520] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 7.8] [Reference Citation Analysis]
41 Sano T, Coit DG, Kim HH, Roviello F, Kassab P, Wittekind C, Yamamoto Y, Ohashi Y. Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project. Gastric Cancer. 2017;20:217-225. [PMID: 26897166 DOI: 10.1007/s10120-016-0601-9] [Cited by in Crossref: 170] [Cited by in F6Publishing: 163] [Article Influence: 28.3] [Reference Citation Analysis]
42 Chen Y, Zhang Z, Jiang G, Zhao K. Gross tumor volume is the prognostic factor for squamous cell esophageal cancer patients treated with definitive radiotherapy. J Thorac Dis 2016;8:1155-61. [PMID: 27293832 DOI: 10.21037/jtd.2016.04.08] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
43 Tian R, Yan H, Zhang F, Sun P, Wu AR, Zhang M, Jiang YL, Wu J, Lu YH, Xu QY, Zhan XH, Zhang RX, Qian LT, He J. Cumulative score based on preoperative plasma fibrinogen and serum C-reactive protein could predict long-term survival for esophageal squamous cell carcinoma. Oncotarget 2016;7:61533-43. [PMID: 27517497 DOI: 10.18632/oncotarget.11145] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
44 Akutsu Y, Matsubara H. The significance of lymph node status as a prognostic factor for esophageal cancer. Surg Today. 2011;41:1190-1195. [PMID: 21874413 DOI: 10.1007/s00595-011-4542-y] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
45 Blum MA, Taketa T, Sudo K, Wadhwa R, Skinner HD, Ajani JA. Chemoradiation for Esophageal Cancer. Thoracic Surgery Clinics 2013;23:551-8. [DOI: 10.1016/j.thorsurg.2013.07.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
46 Wang J, Zhang T, Shen X, Liu J, Zhao D, Sun Y, Wang L, Liu Y, Gong X, Liu Y, Zhu Z, Xue F. Serum metabolomics for early diagnosis of esophageal squamous cell carcinoma by UHPLC-QTOF/MS. Metabolomics 2016;12. [DOI: 10.1007/s11306-016-1050-5] [Cited by in Crossref: 48] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
47 Liu J, Wei Z, Zhang J, Hu W, Ma Z, Liu Q. Which factors are associated with extremely short-term survival after surgery in patients with esophageal squamous cell carcinoma? Asia Pac J Clin Oncol 2016;12:308-13. [PMID: 27220635 DOI: 10.1111/ajco.12503] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
48 Oetzmann von Sochaczewski C, Haist T, Pauthner M, Mann M, Fisseler-Eckhoff A, Braun S, Ell C, Lorenz D. The overall metastatic rate in early esophageal adenocarcinoma: long-time follow-up of surgically treated patients. Dis Esophagus 2019;32:doy127. [PMID: 30596900 DOI: 10.1093/dote/doy127] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Rice TW, Murthy SC, Mason DP, Rybicki LA, Yerian LM, Dumot JA, Rodriguez CP, Blackstone EH. Esophagectomy for clinical high-grade dysplasia. European Journal of Cardio-Thoracic Surgery 2011;40:113-9. [DOI: 10.1016/j.ejcts.2010.10.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
50 Becker K, Reim D, Novotny A, Zum Büschenfelde CM, Engel J, Friess H, Höfler H, Langer R. Proposal for a multifactorial prognostic score that accurately classifies 3 groups of gastric carcinoma patients with different outcomes after neoadjuvant chemotherapy and surgery. Ann Surg. 2012;256:1002-1007. [PMID: 22968067 DOI: 10.1097/sla.0b013e318262a591] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
51 Wei XL, Zhang DS, He MM, Jin Y, Wang DS, Zhou YX, Bai L, Li ZZ, Luo HY, Wang FH, Xu RH. The predictive value of alkaline phosphatase and lactate dehydrogenase for overall survival in patients with esophageal squamous cell carcinoma. Tumour Biol 2016;37:1879-87. [PMID: 26323257 DOI: 10.1007/s13277-015-3851-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
52 Davison JM, Ellis ST, Foxwell TJ, Luketich JD, Gibson MK, Kuan SF, Nason KS. MUC2 expression is an adverse prognostic factor in superficial gastroesophageal adenocarcinomas. Hum Pathol 2014;45:540-8. [PMID: 24290360 DOI: 10.1016/j.humpath.2013.10.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
53 Smith DD, Nelson RA, Schwarz RE. A comparison of five competing lymph node staging schemes in a cohort of resectable gastric cancer patients. Ann Surg Oncol. 2014;21:875-882. [PMID: 24242677 DOI: 10.1245/s10434-013-3356-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
54 Pennathur A, Gooding WE, Nason KS, Luketich JD. Reply to Letter: "Poorer Survival for Stage IIa Patients After Minimally Invasive Esophagectomy". Ann Surg 2015;262:e45-7. [PMID: 25590498 DOI: 10.1097/SLA.0000000000000864] [Reference Citation Analysis]
55 Feng JF, Sheng C, Zhao Q, Chen P. Prognostic value of mean platelet volume/platelet count ratio in patients with resectable esophageal squamous cell carcinoma: a retrospective study. PeerJ 2019;7:e7246. [PMID: 31328033 DOI: 10.7717/peerj.7246] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
56 Jang JY, Yu J, Song KJ, Jo YY, Yoo YJ, Kim SB, Park SR, Kim YH, Kim HR, Kim JH. Prognostic significance of lymph node ratio after neoadjuvant chemoradiation therapy for esophageal squamous cell carcinoma. Radiat Oncol J 2020;38:244-52. [PMID: 33233030 DOI: 10.3857/roj.2020.00850] [Reference Citation Analysis]
57 Zhang H, Guo XW, Yin XX, Liu YC, Ji SJ. Nomogram-Integrated C-Reactive Protein/Albumin Ratio Predicts Efficacy And Prognosis In Patients With Thoracic Esophageal Squamous Cell Carcinoma Receiving Chemoradiotherapy. Cancer Manag Res 2019;11:9459-68. [PMID: 31819611 DOI: 10.2147/CMAR.S228113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
58 Zhao LY, Wang JJ, Zhao YL, Chen XZ, Yang K, Chen XL, Zhang WH, Liu K, Song XH, Zheng JB, Zhou ZG, Yu PW, Li Y, Hu JK. Superiority of Tumor Location-Modified Lauren Classification System for Gastric Cancer: A Multi-Institutional Validation Analysis.Ann Surg Oncol. 2018;25:3257-3263. [PMID: 30051368 DOI: 10.1245/s10434-018-6654-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
59 Zhao LY, Li CC, Jia LY, Chen XL, Zhang WH, Chen XZ, Yang K, Liu K, Wang YG, Xue L, Zhang B, Chen ZX, Chen JP, Zhou ZG, Hu JK. Superiority of lymph node ratio-based staging system for prognostic prediction in 2575 patients with gastric cancer: validation analysis in a large single center. Oncotarget 2016;7:51069-81. [PMID: 27363014 DOI: 10.18632/oncotarget.9714] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
60 Feng JF, Chen S, Yang X. Combination of c-reactive protein and squamous cell carcinoma antigen in predicting postoperative prognosis for patients with squamous cell carcinoma of the esophagus. Oncotarget 2017;8:63132-9. [PMID: 28968977 DOI: 10.18632/oncotarget.18667] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
61 O'neill JR, Stephens NA, Save V, Kamel HM, Phillips HA, Driscoll PJ, Paterson-brown S. Defining a positive circumferential resection margin in oesophageal cancer and its implications for adjuvant treatment. British Journal of Surgery 2013;100:1055-63. [DOI: 10.1002/bjs.9145] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
62 Sisic L, Blank S, Weichert W, Jäger D, Springfeld C, Hochreiter M, Büchler M, Ott K. Prognostic impact of lymph node involvement and the extent of lymphadenectomy (LAD) in adenocarcinoma of the esophagogastric junction (AEG). Langenbecks Arch Surg 2013;398:973-81. [PMID: 23887283 DOI: 10.1007/s00423-013-1101-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
63 Ning ZH, Wang ZG, Chen J, Li XD, Chen LJ, Xu B, Gu WD, Shao YJ, Xu Y, Huang J, Pei HL, Jiang JT. Proposed Modification of Nodal Staging as an Alternative to the Seventh Edition of the American Joint Committee on Cancer Tumor-Node-Metastasis Staging System Improves the Prognostic Prediction in the Resected Esophageal Squamous-Cell Carcinoma. J Thorac Oncol 2015;10:1091-8. [PMID: 26134226 DOI: 10.1097/JTO.0000000000000580] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
64 Reid TD, Sanyaolu LN, Chan D, Williams GT, Lewis WG. Relative prognostic value of TNM7 vs TNM6 in staging oesophageal cancer. Br J Cancer 2011;105:842-6. [PMID: 21847117 DOI: 10.1038/bjc.2011.320] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
65 Berry MF, Zeyer-Brunner J, Castleberry AW, Martin JT, Gloor B, Pietrobon R, D'Amico TA, Worni M. Treatment modalities for T1N0 esophageal cancers: a comparative analysis of local therapy versus surgical resection. J Thorac Oncol 2013;8:796-802. [PMID: 24614244 DOI: 10.1097/JTO.0b013e3182897bf1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
66 Heiden BT, Patel N, Nancarrow DJ, Hermann M, Brown RKJ, Orringer MB, Lin J, Chang AC, Carrott PW, Lynch WR, Zhao L, Beer DG, Reddy RM. Positron Emission Tomography 18F-Fluorodeoxyglucose Uptake Correlates with KRAS and EMT Gene Signatures in Operable Esophageal Adenocarcinoma. J Surg Res 2018;232:621-8. [PMID: 30463782 DOI: 10.1016/j.jss.2018.06.046] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
67 Liu S, Ge X, Gao Z, Zhou Q, Shi Y, Jiang W, Yang M, Sun X. Clinicopathological analysis of 67 cases of esophageal neuroendocrine carcinoma and the effect of postoperative adjuvant therapy on prognosis. Medicine (Baltimore) 2021;100:e27302. [PMID: 34713821 DOI: 10.1097/MD.0000000000027302] [Reference Citation Analysis]
68 Xu XL, Zheng WH, Zhu SM, Zhao A, Mao WM. The Prognostic Impact of Lymph Node Involvement in Large Scale Operable Node-Positive Esophageal Squamous Cell Carcinoma Patients: A 10-Year Experience. PLoS One 2015;10:e0133076. [PMID: 26177369 DOI: 10.1371/journal.pone.0133076] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
69 Sonavane S, Watts J, Terry N, Singh S. Expected and unexpected imaging features after oesophageal cancer treatment. Clinical Radiology 2014;69:e358-66. [DOI: 10.1016/j.crad.2014.04.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
70 Yeh JH, Huang RY, Lee CT, Lin CW, Hsu MH, Wu TC, Hsiao PJ, Wang WL. Long-term outcomes of endoscopic submucosal dissection and comparison to surgery for superficial esophageal squamous cancer: a systematic review and meta-analysis. Therap Adv Gastroenterol 2020;13:1756284820964316. [PMID: 33224272 DOI: 10.1177/1756284820964316] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Reeh M, Metze J, Uzunoglu FG, Nentwich M, Ghadban T, Wellner U, Bockhorn M, Kluge S, Izbicki JR, Vashist YK. The PER (Preoperative Esophagectomy Risk) Score: A Simple Risk Score to Predict Short-Term and Long-Term Outcome in Patients with Surgically Treated Esophageal Cancer. Medicine (Baltimore) 2016;95:e2724. [PMID: 26886613 DOI: 10.1097/MD.0000000000002724] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
72 Singhi AD, Seethala RR, Nason K, Foxwell TJ, Roche RL, McGrath KM, Levy RM, Luketich JD, Davison JM. Undifferentiated carcinoma of the esophagus: a clinicopathological study of 16 cases. Hum Pathol 2015;46:366-75. [PMID: 25582499 DOI: 10.1016/j.humpath.2014.11.021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
73 Rice TW, Blackstone EH. pT2N0M0 esophageal squamous cell cancer: Location, grade, and statistics. The Journal of Thoracic and Cardiovascular Surgery 2013;145:1426-7. [DOI: 10.1016/j.jtcvs.2013.02.040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
74 Speicher PJ, Englum BR, Ganapathi AM, Mulvihill MS, Hartwig MG, Onaitis MW, D’amico TA, Berry MF. Adjuvant Chemotherapy Is Associated with Improved Survival after Esophagectomy without Induction Therapy for Node-Positive Adenocarcinoma. Journal of Thoracic Oncology 2015;10:181-8. [DOI: 10.1097/jto.0000000000000384] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 2.1] [Reference Citation Analysis]
75 Speicher PJ, Englum BR, Ganapathi AM, Wang X, Hartwig MG, D'Amico TA, Berry MF. Traveling to a High-volume Center is Associated With Improved Survival for Patients With Esophageal Cancer. Ann Surg. 2017;265:743-749. [PMID: 28266965 DOI: 10.1097/sla.0000000000001702] [Cited by in Crossref: 48] [Cited by in F6Publishing: 19] [Article Influence: 9.6] [Reference Citation Analysis]
76 Fukui T, Taniguchi T, Kawaguchi K, Fukumoto K, Nakamura S, Sakao Y, Yokoi K. Comparisons of the clinicopathological features and survival outcomes between lung cancer patients with adenocarcinoma and squamous cell carcinoma. Gen Thorac Cardiovasc Surg 2015;63:507-13. [DOI: 10.1007/s11748-015-0564-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
77 Wittekind C, Tannapfel A. Aktuelles TNM-System der gastrointestinalen Tumoren Teil I. Pathologe 2010;31:344-7. [DOI: 10.1007/s00292-010-1304-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
78 Sakanaka K, Ishida Y, Itasaka S, Ezoe Y, Aoyama I, Miyamoto S, Horimatsu T, Muto M, Hiraoka M. Identification of a predictive factor for distant metastasis in esophageal squamous cell carcinoma after definitive chemoradiotherapy. Int J Clin Oncol 2016;21:899-908. [PMID: 26936851 DOI: 10.1007/s10147-016-0967-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
79 Rice TW, Ishwaran H, Blackstone EH, Hofstetter WL, Kelsen DP, Apperson-Hansen C; Worldwide Esophageal Cancer Collaboration Investigators. Recommendations for clinical staging (cTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus 2016;29:913-9. [PMID: 27905171 DOI: 10.1111/dote.12540] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 10.0] [Reference Citation Analysis]
80 Zhang X, Li M, Meng X, Kong L, Zhang Y, Wei G, Zhang X, Shi F, Hu M, Zhang G. Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma. Radiat Oncol. 2014;9:64. [PMID: 24571804 DOI: 10.1186/1748-717X-9-64] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
81 Volkweis BS, Gurski RR, Meurer L, Pretto GG, Mazzini Gda S, Edelweiss MI. Ki-67 Antigen Overexpression Is Associated with the Metaplasia-Adenocarcinoma Sequence in Barrett's Esophagus. Gastroenterol Res Pract 2012;2012:639748. [PMID: 22844273 DOI: 10.1155/2012/639748] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
82 van der Wel MJ, Klaver E, Pouw RE, Brosens LAA, Biermann K, Doukas M, Huysentruyt C, Karrenbeld A, Ten Kate FJW, Kats-Ugurlu G, van der Laan J, van Lijnschoten I, Moll FCP, Offerhaus GJA, Ooms AHAG, Seldenrijk CA, Visser M, Tijssen JG, Meijer SL, Bergman JJGHM. Significant variation in histopathological assessment of endoscopic resections for Barrett's neoplasia suggests need for consensus reporting: propositions for improvement. Dis Esophagus 2021:doab034. [PMID: 34100554 DOI: 10.1093/dote/doab034] [Reference Citation Analysis]
83 Yasuda T, Higuchi I, Yano M, Miyata H, Yamasaki M, Takiguchi S, Fujiwara Y, Hatazawa J, Doki Y. The impact of ¹⁸F-fluorodeoxyglucose positron emission tomography positive lymph nodes on postoperative recurrence and survival in resectable thoracic esophageal squamous cell carcinoma. Ann Surg Oncol 2012;19:652-60. [PMID: 21769466 DOI: 10.1245/s10434-011-1928-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
84 Zhang F, Sun P, Wang ZQ, Wang de S, Wang Y, Zhang DS, Wang FH, Fu JH, Xu RH, Li YH. Low preoperative albumin-globulin score predicts favorable survival in esophageal squamous cell carcinoma. Oncotarget 2016;7:30550-60. [PMID: 27105522 DOI: 10.18632/oncotarget.8868] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
85 Yang AJ, Choi SH, Byun HK, Kim HJ, Choi J, Lee YC, Lee SK, Park KR, Lee CG. Management of Clinical T1N0M0 Esophageal Cancer. Gut Liver. 2019;13:315-324. [PMID: 30600672 DOI: 10.5009/gnl18254] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
86 Sun HB, Li Y, Liu XB, Zhang RX, Wang ZF, Zheng Y, Qin JJ, Li HM, Chen XK, Wu Z. Embedded Three-Layer Esophagogastric Anastomosis Reduces Morbidity and Improves Short-Term Outcomes After Esophagectomy for Cancer. Ann Thorac Surg. 2016;101:1131-1138. [PMID: 26687140 DOI: 10.1016/j.athoracsur.2015.09.094] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
87 Zaninotto G, Bennett C. Surveillance for low-grade dysplastic Barrett's oesophagus: one size fits all? World J Surg 2015;39:578-85. [PMID: 24919861 DOI: 10.1007/s00268-014-2661-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
88 Zeng Y, Liang W, Liu J, He J. Endoscopic Treatment Versus Esophagectomy for Early-Stage Esophageal Cancer: a Population-Based Study Using Propensity Score Matching. J Gastrointest Surg. 2017;21:1977-1983. [PMID: 29030780 DOI: 10.1007/s11605-017-3563-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
89 Rice TW, Ishwaran H, Hofstetter WL, Schipper PH, Kesler KA, Law S, Lerut EM, Denlinger CE, Salo JA, Scott WJ, Watson TJ, Allen MS, Chen LQ, Rusch VW, Cerfolio RJ, Luketich JD, Duranceau A, Darling GE, Pera M, Apperson-Hansen C, Blackstone EH. Esophageal Cancer: Associations With (pN+) Lymph Node Metastases. Ann Surg. 2017;265:122-129. [PMID: 28009736 DOI: 10.1097/sla.0000000000001594] [Cited by in Crossref: 50] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
90 Feng JF, Huang Y, Lu WS, Chen QX. Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Langenbecks Arch Surg. 2013;398:1115-1122. [PMID: 24013712 DOI: 10.1007/s00423-013-1111-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
91 Chen H, Chu LY, Li XH, Peng YH, Liu CT, Tian LR, Xie JJ, Xu YW. ApoB/ApoA-1 Ratio as a Novel Prognostic Predictor in Patients With Primary Small Cell Carcinoma of the Esophagus. Front Oncol 2020;10:610. [PMID: 32391278 DOI: 10.3389/fonc.2020.00610] [Reference Citation Analysis]
92 Torrance AD, Almond LM, Fry J, Wadley MS, Lyburn ID. Has integrated 18F FDG PET/CT improved staging, reduced early recurrence or increased survival in oesophageal cancer? Surgeon. 2015;13:19-33. [PMID: 24206935 DOI: 10.1016/j.surge.2013.09.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
93 Yam PC, Tong D, Law S. Comparisons of sixth and seventh edition of the American Joint Cancer Committee staging systems for esophageal cancer. Ann Surg Oncol 2014;21:583-8. [PMID: 24197762 DOI: 10.1245/s10434-013-3335-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
94 Lerut T. Cancer of the oesophagus and gastrooesophageal junction: neoadjuvant therapy should not be a surrogate for suboptimal lymphadenectomy. Eur J Cardiothorac Surg 2012;42:664-6. [PMID: 22491660 DOI: 10.1093/ejcts/ezs094] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
95 Zhu K, Xu Y, Fu J, Mohamud FA, Duan Z, Tan S, Zhao Z, Chen P, Zong L. Proximal Gastrectomy versus Total Gastrectomy for Siewert Type II Adenocarcinoma of the Esophagogastric Junction: A Comprehensive Analysis of Data from the SEER Registry. Dis Markers 2019;2019:9637972. [PMID: 31976023 DOI: 10.1155/2019/9637972] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
96 Yoon HH, Lewis MA, Shi Q, Khan M, Cassivi SD, Diasio RB, Sinicrope FA. Prognostic impact of body mass index stratified by smoking status in patients with esophageal adenocarcinoma. J Clin Oncol 2011;29:4561-7. [PMID: 21990414 DOI: 10.1200/JCO.2011.37.1260] [Cited by in Crossref: 48] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
97 Bhamidipati CM, Stukenborg GJ, Thomas CJ, Lau CL, Kozower BD, Jones DR. Pathologic lymph node ratio is a predictor of survival in esophageal cancer. Ann Thorac Surg. 2012;94:1643-1651. [PMID: 22621876 DOI: 10.1016/j.athoracsur.2012.03.078] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
98 Vay C, Hosch SB, Stoecklein NH, Klein CA, Vallböhmer D, Link BC, Yekebas EF, Izbicki JR, Knoefel WT, Scheunemann P. Integrin expression in esophageal squamous cell carcinoma: loss of the physiological integrin expression pattern correlates with disease progression. PLoS One 2014;9:e109026. [PMID: 25398092 DOI: 10.1371/journal.pone.0109026] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
99 Hwang SH, Kim HI, Song JS, Lee MH, Kwon SJ, Kim MG. The Ratio-Based N Staging System Can More Accurately Reflect the Prognosis of T4 Gastric Cancer Patients with D2 Lymphadenectomy Compared with the 7th American Joint Committee on Cancer/Union for International Cancer Control Staging System. J Gastric Cancer 2016;16:207-14. [PMID: 28053806 DOI: 10.5230/jgc.2016.16.4.207] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
100 Paul S, Altorki N. Outcomes in the management of esophageal cancer. J Surg Oncol. 2014;110:599-610. [PMID: 25146593 DOI: 10.1002/jso.23759] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]
101 Ishwaran H, Blackstone EH, Apperson-Hansen C, Rice TW. A novel approach to cancer staging: application to esophageal cancer. Biostatistics 2009;10:603-20. [PMID: 19502615 DOI: 10.1093/biostatistics/kxp016] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
102 Rice TW. Staging of esophageal cancer: TNM and beyond. Esophagus 2010;7:189-95. [DOI: 10.1007/s10388-010-0246-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
103 Feng JF, Liu JS, Huang Y. Lymphopenia predicts poor prognosis in patients with esophageal squamous cell carcinoma. Medicine (Baltimore). 2014;93:e257. [PMID: 25501097 DOI: 10.1097/md.0000000000000257] [Cited by in Crossref: 40] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
104 Wang Y, Li J, Chang S, Zhou K, Che G. Low Albumin to Fibrinogen Ratio Predicts Poor Overall Survival in Esophageal Small Cell Carcinoma Patients: A Retrospective Study. Cancer Manag Res 2020;12:2675-83. [PMID: 32368146 DOI: 10.2147/CMAR.S250293] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
105 Osterman TJ, Terry M, Miller RS. Improving Cancer Data Interoperability: The Promise of the Minimal Common Oncology Data Elements (mCODE) Initiative. JCO Clin Cancer Inform 2020;4:993-1001. [PMID: 33136433 DOI: 10.1200/CCI.20.00059] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 14.0] [Reference Citation Analysis]
106 Takemura K, Kawachi H, Eishi Y, Kitagaki K, Negi M, Kobayashi M, Uchida K, Inoue J, Inazawa J, Kawano T, Board PG. γ-Glutamylcyclotransferase as a novel immunohistochemical biomarker for the malignancy of esophageal squamous tumors. Human Pathology 2014;45:331-41. [DOI: 10.1016/j.humpath.2013.09.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
107 Huang L, Xu AM. Adenocarcinoma of esophagogastric junction: controversial classification, surgical management, and clinicopathology. Chin J Cancer Res. 2014;26:226-230. [PMID: 25035645 DOI: 10.3978/j.issn.1000-9604.2014.06.14] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
108 Mawhinney MR, Glasgow RE. Current treatment options for the management of esophageal cancer. Cancer Manag Res 2012;4:367-77. [PMID: 23152702 DOI: 10.2147/CMAR.S27593] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
109 Mitchell KG, Nelson DB, Corsini EM, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Sepesi B, Walsh GL, Bhutani MS, Maru DM, Wu CC, Nguyen QN, Ajani JA, Swisher SG, Hofstetter WL. Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience. Dis Esophagus 2020;33:doz067. [PMID: 31313820 DOI: 10.1093/dote/doz067] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
110 Pines G, Klein Y, Buyeviz V, Idelevich E, Kashtan H. Disease-Related Mortality within the First Year after Subtotal Esophagectomy for Cancer. Ann Surg Oncol 2011;18:1139-44. [DOI: 10.1245/s10434-010-1386-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
111 Zhang DY, Huang GR, Ku JW, Zhao XK, Song X, Xu RH, Han WL, Zhou FY, Wang R, Wei MX, Wang LD. Development and validation of a prognostic nomogram model for Chinese patients with primary small cell carcinoma of the esophagus. World J Clin Cases 2021; 9(30): 9011-9022 [PMID: 34786384 DOI: 10.12998/wjcc.v9.i30.9011] [Reference Citation Analysis]
112 Shim YM, Park JS, Lee M, Kim D, Kim K. Can common hepatic artery lymph node dissection be safely omitted in surgery for clinical T1N0 thoracic esophageal squamous cell carcinoma?: Can common hepatic artery lymph node dissection be omitted in surgery for T1N0 esophageal cancer? Dis Esophagus 2013;26:272-5. [DOI: 10.1111/j.1442-2050.2012.01361.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
113 Guan CT, Song GH, Li BY, Gong YW, Hao CQ, Xue LY, Chen WQ, Wei WQ. Endoscopy screening effect on stage distributions of esophageal cancer: A cluster randomized cohort study in China. Cancer Sci 2018;109:1995-2002. [PMID: 29635717 DOI: 10.1111/cas.13606] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
114 Chen D, Wang W, Chen Y, Hu J, Yang M, Mo J, Wen Z. Recurrence and prognostic model for identifying patients at risk for esophageal cancer after surgery. Cancer Manag Res 2018;10:6109-20. [PMID: 30538559 DOI: 10.2147/CMAR.S186194] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
115 Wang P, Yang M, Wang X, Zhao Z, Li M, Yu J. A nomogram for the predicting of survival in patients with esophageal squamous cell carcinoma undergoing definitive chemoradiotherapy. Ann Transl Med 2021;9:233. [PMID: 33708860 DOI: 10.21037/atm-20-1460] [Reference Citation Analysis]
116 Xi M, Liao Z, Deng W, Xu C, Komaki R, Blum M, Hofstetter WL, Ho L, Lin SH. A Prognostic Scoring Model for the Utility of Induction Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in Esophageal Cancer. J Thorac Oncol 2017;12:1001-10. [PMID: 28351804 DOI: 10.1016/j.jtho.2017.03.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
117 Francis AM, Sepesi B, Correa AM, Blum MA, Erasmus JJ, Lee JH, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Welsh JW, Swisher SG, Hofstetter WL; University of Texas MD Anderson Esophageal Cancer Group. The influence of histopathologic tumor viability on long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinoma. Ann Surg 2013;258:500-7. [PMID: 24022442 DOI: 10.1097/SLA.0b013e3182a196f4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 3.1] [Reference Citation Analysis]
118 Singhi AD, Foxwell TJ, Nason K, Cressman KL, McGrath KM, Sun W, Bahary N, Zeh HJ, Levy RM, Luketich JD, Davison JM. Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival. Am J Surg Pathol 2015;39:487-95. [PMID: 25634752 DOI: 10.1097/PAS.0000000000000356] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 2.9] [Reference Citation Analysis]
119 D'Annoville T, D'Journo XB, Loundou A, Trousse D, Dahan L, Doddoli C, Seitz JF, Thomas PA. Prognostic impact of the extracapsular lymph node involvement on disease-free survival according to the 7th edition of American Joint Committee on Cancer Staging System. Eur J Cardiothorac Surg 2013;44:e207-11; discussion e211. [PMID: 23818566 DOI: 10.1093/ejcts/ezt332] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
120 Zhou GQ, Wu CF, Deng B, Gao TS, Lv JW, Lin L, Chen FP, Kou J, Zhang ZX, Huang XD, Zheng ZQ, Ma J, Liang JH, Sun Y. An optimal posttreatment surveillance strategy for cancer survivors based on an individualized risk-based approach. Nat Commun 2020;11:3872. [PMID: 32747627 DOI: 10.1038/s41467-020-17672-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
121 Zhao Q, Chen S, Feng JF. A novel inflammation-based prognostic index for patients with esophageal squamous cell carcinoma: neutrophil lymphocyte ratio/albumin ratio. Oncotarget 2017;8:103535-42. [PMID: 29262582 DOI: 10.18632/oncotarget.21989] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
122 Cho JH, Kim TN. Long-term survival after concurrent chemoradiation therapy for esophageal cancer with tracheal invasion. Korean J Intern Med 2015;30:931-3. [PMID: 26552472 DOI: 10.3904/kjim.2015.30.6.931] [Reference Citation Analysis]
123 Jia Y, Wang N, Wang J, Tian H, Ma W, Wang K, Tan B, Zhang G, Yang S, Bai B, Cheng Y. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis. Ann Surg Oncol 2014;21:329-36. [PMID: 23982252 DOI: 10.1245/s10434-013-3225-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
124 Berry MF. Esophageal Cancer: Improvements in Treatment, Staging, and Now Prognostic Indicators? Semin Thorac Cardiovasc Surg 2016;28:559-60. [PMID: 28043476 DOI: 10.1053/j.semtcvs.2016.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
125 Rice TW. Esophageal Cancer Staging. Korean J Thorac Cardiovasc Surg 2015;48:157-63. [PMID: 26078921 DOI: 10.5090/kjtcs.2015.48.3.157] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
126 Yamada I, Hikishima K, Miyasaka N, Kawano T, Tokairin Y, Ito E, Kobayashi D, Eishi Y, Okano H. Esophageal carcinoma: ex vivo evaluation with diffusion-tensor MR imaging and tractography at 7 T. Radiology 2014;272:164-73. [PMID: 24654973 DOI: 10.1148/radiol.14132170] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
127 Saito H, Ohta A, Abe E, Kaidu M, Shioi M, Nakano T, Oshikane T, Tanaka K, Maruyama K, Kushima N, Tanabe S, Utsunomiya S, Sasamoto R, Aoyama H. Definitive chemoradiotherapy with low-dose continuous 5-fluorouracil reduces hematological toxicity without compromising survival in esophageal squamous cell carcinoma patients. Clin Transl Radiat Oncol 2018;9:12-7. [PMID: 29594245 DOI: 10.1016/j.ctro.2017.12.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
128 Li Q, Wu SG, Gao JM, Xu JJ, Hu LY, Xu T. Impact of esophageal cancer staging on overall survival and disease-free survival based on the 2010 AJCC classification by lymph nodes. J Radiat Res. 2013;54:307-314. [PMID: 23124992 DOI: 10.1093/jrr/rrs096] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
129 Ustaalioğlu BBÖ, Tilki M, Sürmelioğlu A, Bilici A, Gönen C, Ustaalioğlu R, Balvan Ö, Aliustaoğlu M. The clinicopathologic characteristics and prognostic factors of gastroesophageal junction tumors according to Siewert classification. Turk J Surg 2017;33:18-24. [PMID: 28589183 DOI: 10.5152/UCD.2017.3379] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
130 Rice TW, Ishwaran H, Blackstone EH. Oesophageal cancer: location, location, location. Eur J Cardiothorac Surg 2015;48:194-5. [PMID: 25877947 DOI: 10.1093/ejcts/ezv125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
131 Xu L, Li Y, Liu X, Sun H, Zhang R, Zhang J, Zheng Y, Wang Z, Liu S, Chen X. Treatment Strategies and Prognostic Factors of Limited-Stage Primary Small Cell Carcinoma of the Esophagus. J Thorac Oncol. 2017;12:1834-1844. [PMID: 29024756 DOI: 10.1016/j.jtho.2017.09.1966] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
132 Furlong H, Bass G, Breathnach O, O'Neill B, Leen E, Walsh TN. Targeting therapy for esophageal cancer in patients aged 70 and over. J Geriatr Oncol 2013;4:107-13. [PMID: 24071535 DOI: 10.1016/j.jgo.2012.12.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
133 Su XD, Zhang X, Xie HJ, Lin P, Zhang L, Rong T. Younger women have a better prognosis among patients with esophageal squamous cell carcinoma after esophagectomy. J Thorac Dis 2016;8:872-9. [PMID: 27162661 DOI: 10.21037/jtd.2016.03.49] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
134 Kleinberg L, Brock M, Gibson M. Management of Locally Advanced Adenocarcinoma of the Esophagus and Gastroesophageal Junction: Finally a Consensus. Curr Treat Options Oncol 2015;16:35. [PMID: 26112428 DOI: 10.1007/s11864-015-0352-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
135 Chen YH, Huang CH, Lu HI, Chen CH, Huang WT, Hsieh MJ, Rau KM, Chang AY, Lin WC, Li SH. Prognostic impact of renin-angiotensin system blockade in esophageal squamous cell carcinoma. J Renin Angiotensin Aldosterone Syst. 2015;16:1185-1192. [PMID: 24961505 DOI: 10.1177/1470320314535275] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
136 Yang H, Wei J, Xu Y, Liu J, Lin P, Rong T, Fu J. Modification of Nodal Categories in the Seventh American Joint Committee on Cancer Staging System for Esophageal Squamous Cell Carcinoma in Chinese Patients. The Annals of Thoracic Surgery 2011;92:216-24. [DOI: 10.1016/j.athoracsur.2011.03.032] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
137 Bronson NW, Luna RA, Hunter JG. Tailoring esophageal cancer surgery. Semin Thorac Cardiovasc Surg 2012;24:275-87. [PMID: 23465676 DOI: 10.1053/j.semtcvs.2012.11.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
138 Feng JF, Zhao JM, Chen S, Chen QX. Naples Prognostic Score: A Novel Prognostic Score in Predicting Cancer-Specific Survival in Patients With Resected Esophageal Squamous Cell Carcinoma. Front Oncol 2021;11:652537. [PMID: 34123805 DOI: 10.3389/fonc.2021.652537] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
139 Duan XF, Tang P, Shang XB, Jiang HJ, Yu ZT. The prevalence of lymph node metastasis for pathological T1 esophageal cancer: a retrospective study of 143 cases. Surg Oncol. 2018;27:1-6. [PMID: 29549895 DOI: 10.1016/j.suronc.2017.11.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
140 Frankel A, Nancarrow D, Wayte N, Barbour A. Clinical issues in oesophageal adenocarcinoma: could DNA copy number hold the key? ANZ J Surg 2012;82:599-606. [PMID: 22856687 DOI: 10.1111/j.1445-2197.2012.06144.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
141 Chung TR, Kim JH, Lee IJ, Cho Y, Kim JW, Lee CG, Jung DH, Park JJ, Youn YH, Park H. Different prognosis of patients with esophageal carcinoma with M1a and regional node involvement. Dig Liver Dis 2019;51:1610-6. [PMID: 31175014 DOI: 10.1016/j.dld.2019.05.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
142 Zhang D, Ku J, Liu R, Wu H, Liang G, Wei Y, Chen P, Zhao X, Liu S, Li Y, Yao J, Song X, Wang L. Characterization of serum estradiol level and tissue estrogen receptor immunostaining with clinical response and reproductive factor changes in Chinese female patients with esophageal squamous cell carcinoma. Biomed Pharmacother 2017;93:879-84. [PMID: 28724213 DOI: 10.1016/j.biopha.2017.07.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
143 McNamara MJ, Adelstein DJ. Current developments in the management of locally advanced esophageal cancer. Curr Oncol Rep. 2012;14:342-349. [PMID: 22544559 DOI: 10.1007/s11912-012-0239-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
144 Zeng R, Liu Y, Jiang ZJ, Huang JP, Wang Y, Li XF, Xiong WB, Wu XC, Zhang JR, Wang QE, Zheng YF. EPB41L3 is a potential tumor suppressor gene and prognostic indicator in esophageal squamous cell carcinoma. Int J Oncol 2018;52:1443-54. [PMID: 29568917 DOI: 10.3892/ijo.2018.4316] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
145 Shin KE, Lee KS, Choi JY, Kim HK, Shim YM. Esophageal malignancy and staging. Semin Roentgenol 2013;48:344-53. [PMID: 24034266 DOI: 10.1053/j.ro.2013.03.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
146 Sugawara K, Yamashita H, Uemura Y, Mitsui T, Yagi K, Nishida M, Aikou S, Mori K, Nomura S, Seto Y. Numeric pathologic lymph node classification shows prognostic superiority to topographic pN classification in esophageal squamous cell carcinoma. Surgery 2017;162:846-56. [PMID: 28739092 DOI: 10.1016/j.surg.2017.06.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
147 Liu J, Xie X, Zhou C, Peng S, Rao D, Fu J. Which factors are associated with actual 5-year survival of oesophageal squamous cell carcinoma? Eur J Cardiothorac Surg 2012;41:e7-11. [PMID: 22219482 DOI: 10.1093/ejcts/ezr240] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 4.2] [Reference Citation Analysis]
148 Erhunmwunsee L, Englum BR, Onaitis MW, D'Amico TA, Berry MF. Impact of pretreatment imaging on survival of esophagectomy after induction therapy for esophageal cancer: who should be given the benefit of the doubt?: esophagectomy outcomes of patients with suspicious metastatic lesions. Ann Surg Oncol. 2015;22:1020-1025. [PMID: 25234017 DOI: 10.1245/s10434-014-4079-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
149 Huang Y, Liu JS, Feng JF. The combination of preoperative serum C-reactive protein and carcinoembryonic antigen is a useful prognostic factor in patients with esophageal squamous cell carcinoma: a combined ROC analysis. Onco Targets Ther 2015;8:795-803. [PMID: 25914550 DOI: 10.2147/OTT.S77378] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
150 Landau MS, Hastings SM, Foxwell TJ, Luketich JD, Nason KS, Davison JM. Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma. Mod Pathol 2014;27:1578-89. [PMID: 24762549 DOI: 10.1038/modpathol.2014.66] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
151 Schuhmacher C, Novotny A, Feith M, Friess H. Die neue TNM-Klassifikation der Tumoren des ösophagogastralen Übergangs: Chirurgische Konsequenzen. Chirurg 2012;83:23-30. [DOI: 10.1007/s00104-011-2146-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
152 Zhang JQ, Hooker CM, Brock MV, Shin J, Lee S, How R, Franco N, Prevas H, Hulbert A, Yang SC. Neoadjuvant chemoradiation therapy is beneficial for clinical stage T2 N0 esophageal cancer patients due to inaccurate preoperative staging. Ann Thorac Surg 2012;93:429-35; discussion 436-7. [PMID: 22269708 DOI: 10.1016/j.athoracsur.2011.10.061] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
153 Wei Q, Li X, Zhu Z, Yu W, Qin G, Chen H, Gu Y, Zhao K, Fu X, Sun M. Expression and prognostic value of FOXP1 in esophageal squamous cell carcinoma. Pathology - Research and Practice 2019;215:152645. [DOI: 10.1016/j.prp.2019.152645] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
154 Hu W, Liang Y, Zhang S, Hu Y, Liu J. Impact of tumor location on prognosis in patients with thoracic esophageal squamous cell carcinoma. Eur Surg 2013;45:200-4. [DOI: 10.1007/s10353-013-0223-y] [Reference Citation Analysis]
155 Rice TW, Blackstone EH. Esophageal cancer staging: past, present, and future. Thorac Surg Clin. 2013;23:461-469. [PMID: 24199696 DOI: 10.1016/j.thorsurg.2013.07.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
156 O'Brien R, Ishwaran H. A Random Forests Quantile Classifier for Class Imbalanced Data. Pattern Recognit 2019;90:232-49. [PMID: 30765897 DOI: 10.1016/j.patcog.2019.01.036] [Cited by in Crossref: 42] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
157 Chen Q, Yu L, Hao C, Wang J, Liu S, Zhang M, Zhang S, Guo L, Quan P, Germain P, Zhang Y, Sun X. Effectiveness evaluation of organized screening for esophageal cancer: a case-control study in Linzhou city, China. Sci Rep 2016;6:35707. [PMID: 27759094 DOI: 10.1038/srep35707] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
158 Cartwright E, Keane FK, Enzinger PC, Hong T, Chau I. Is There a Precise Adjuvant Therapy for Esophagogastric Carcinoma? American Society of Clinical Oncology Educational Book 2018. [DOI: 10.1200/edbk_200785] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
159 Xie X, Zhang SS, Wen J, Yang H, Luo KJ, Yang F, Hu Y, Fu JH. Prognostic value of HOXB7 mRNA expression in human oesophageal squamous cell cancer. Biomarkers. 2013;18:297-303. [PMID: 23627614 DOI: 10.3109/1354750x.2013.773380] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
160 Yoon HH, Shi Q, Sukov WR, Wiktor AE, Khan M, Sattler CA, Grothey A, Wu TT, Diasio RB, Jenkins RB, Sinicrope FA. Association of HER2/ErbB2 expression and gene amplification with pathologic features and prognosis in esophageal adenocarcinomas. Clin Cancer Res 2012;18:546-54. [PMID: 22252257 DOI: 10.1158/1078-0432.CCR-11-2272] [Cited by in Crossref: 98] [Cited by in F6Publishing: 46] [Article Influence: 9.8] [Reference Citation Analysis]
161 Allanson BM, Kumarasinghe MP. Processing of Surgical Specimen (Esophagogastrectomy) for Esophageal Adenocarcinoma. Methods Mol Biol 2018;1756:85-92. [PMID: 29600362 DOI: 10.1007/978-1-4939-7734-5_8] [Reference Citation Analysis]
162 de Nucci G, Petrone MC, Imperatore N, Asti E, Rossi G, Manes G, Vecchi M, Pastorelli L, Bonavina L, Arcidiacono PG. Staging esophageal cancer: low EUS accuracy in t2n0 patients. Endosc Int Open 2021;9:E313-8. [PMID: 33655027 DOI: 10.1055/a-1336-2505] [Reference Citation Analysis]
163 Liou DZ, Backhus LM, Lui NS, Shrager JB, Berry MF. Induction therapy for locally advanced distal esophageal adenocarcinoma: Is radiation Always necessary? J Thorac Cardiovasc Surg 2018;155:2697-707. [PMID: 29530567 DOI: 10.1016/j.jtcvs.2017.12.136] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
164 Kersting S, Konopke R, Dittert D, Distler M, Rückert F, Gastmeier J, Baretton GB, Saeger HD. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma? J Gastroenterol Hepatol 2009;24:886-95. [PMID: 19655439 DOI: 10.1111/j.1440-1746.2008.05732.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
165 Yu S, Zhang W, Ni W, Xiao Z, Wang Q, Zhou Z, Feng Q, Zhang H, Chen D, Liang J, Lv J, Hui Z, He J, Gao S, Sun K, Fang D, Liu X, Li Y. A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy. Radiother Oncol 2019;140:159-66. [PMID: 31302346 DOI: 10.1016/j.radonc.2019.06.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
166 Dai MM, Wu SG, Zheng H, Chen SY, Li YM, Deng C, Zhou YF, Lin Q. Patterns of regional lymph node recurrence after radical esophagectomy for thoracic esophageal squamous cell carcinoma. Shijie Huaren Xiaohua Zazhi 2014; 22(28): 4237-4242 [DOI: 10.11569/wcjd.v22.i28.4237] [Reference Citation Analysis]
167 Yasuda T, Yano M, Miyata H, Yamasaki M, Takiguchi S, Fujiwara Y, Doki Y. Prognostic Significance of (18)F-fluorodeoxyglucose Positron Emission Tomography (FDG-PET)-Positive Lymph Nodes Following Neoadjuvant Chemotherapy and Surgery for Resectable Thoracic Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2015;22:2599-607. [PMID: 25524011 DOI: 10.1245/s10434-014-4299-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
168 Feng JF, Huang Y, Chen L, Zhao Q. Prognostic analysis of esophageal cancer in elderly patients: metastatic lymph node ratio versus 2010 AJCC classification by lymph nodes. World J Surg Oncol. 2013;11:162. [PMID: 23866060 DOI: 10.1186/1477-7819-11-162] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
169 Yang M, Zhang H, Ma Z, Gong L, Chen C, Ren P, Shang X, Tang P, Jiang H, Yu Z. Log odds of positive lymph nodes is a novel prognostic indicator for advanced ESCC after surgical resection. J Thorac Dis. 2017;9:1182-1189. [PMID: 28616267 DOI: 10.21037/jtd.2017.03.187] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
170 Nieman DR, Peyre CG, Watson TJ, Cao W, Lunt MD, Lada MJ, Han MS, Jones CE, Peters JH. Neoadjuvant treatment response in negative nodes is an important prognosticator after esophagectomy. Ann Thorac Surg 2015;99:277-83. [PMID: 25442991 DOI: 10.1016/j.athoracsur.2014.07.037] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
171 Feng JF, Wang L, Yang X, Jiang YH. Prognostic value of lactate dehydrogenase to albumin ratio (LAR) in patients with resectable esophageal squamous cell carcinoma. Cancer Manag Res 2019;11:7243-51. [PMID: 31447584 DOI: 10.2147/CMAR.S208320] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
172 Nieman DR, Peters JH. Treatment strategies for esophageal cancer. Gastroenterol Clin North Am. 2013;42:187-197. [PMID: 23452638 DOI: 10.1016/j.gtc.2012.11.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
173 Wu XN, Liu CQ, Tian JY, Guo MF, Xu MQ. Prognostic significance of the number of lymph nodes examined in node-negative Siewert type II esophagogastric junction adenocarcinoma. Int J Surg. 2017;41:6-11. [PMID: 28323156 DOI: 10.1016/j.ijsu.2017.03.028] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
174 Chen GP, Huang Y, Yang X, Feng JF. A Nomogram to Predict Prognostic Value of Red Cell Distribution Width in Patients with Esophageal Cancer. Mediators Inflamm. 2015;2015:854670. [PMID: 26578822 DOI: 10.1155/2015/854670] [Cited by in Crossref: 18] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
175 Feng JF, Huang Y, Chen QX. A new inflammation index is useful for patients with esophageal squamous cell carcinoma. Onco Targets Ther 2014;7:1811-5. [PMID: 25336972 DOI: 10.2147/OTT.S68084] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 2.9] [Reference Citation Analysis]
176 Yang Y, Zheng J, Li Y. Comparison of 4 lymph node staging systems for the prognostic prediction of esophagogastric junction adenocarcinoma with ≤15 retrieved lymph nodes. Eur J Surg Oncol 2021:S0748-7983(21)00942-2. [PMID: 34876328 DOI: 10.1016/j.ejso.2021.11.133] [Reference Citation Analysis]
177 van Rossum PSN, Xu C, Fried DV, Goense L, Court LE, Lin SH. The emerging field of radiomics in esophageal cancer: current evidence and future potential. Transl Cancer Res 2016;5:410-23. [PMID: 30687593 DOI: 10.21037/tcr.2016.06.19] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
178 McNamara MJ, Adelstein DJ, Allende DS, Bodmann JW, Ives DI, Murthy SC, Raymond D, Raja S, Rodriguez CP, Sohal D, Stephans KL, Videtic GMM, Rybicki LA. Persistent Dysphagia After Induction Chemotherapy in Patients with Esophageal Adenocarcinoma Predicts Poor Post-Operative Outcomes. J Gastrointest Cancer 2017;48:181-9. [PMID: 27734205 DOI: 10.1007/s12029-016-9881-x] [Reference Citation Analysis]
179 Akutsu Y, Kono T, Uesato M, Hoshino I, Murakami K, Fujishiro T, Imanishi S, Endo S, Toyozumi T, Matsubara H. Are Additional Trace Elements Necessary in Total Parenteral Nutrition for Patients with Esophageal Cancer Receiving Cisplatin-Based Chemotherapy? Biol Trace Elem Res 2012;150:109-15. [DOI: 10.1007/s12011-012-9513-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
180 Giorgetti A, Pallabazzer G, Ripoli A, Solito B, Genovesi D, Lencioni M, Fabrini MG, D'Imporzano S, Pieraccini L, Marzullo P, Santi S. Prognostic Significance of 2-Deoxy-2-[18F]-Fluoro-D-Glucose PET/CT in Patients With Locally Advanced Esophageal Cancer Undergoing Neoadjuvant Chemoradiotherapy Before Surgery: A Nonparametric Approach. Medicine (Baltimore) 2016;95:e3151. [PMID: 27043676 DOI: 10.1097/MD.0000000000003151] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
181 Pei JP, Zhang CD, Fu X, Ba Y, Yue S, Zhao ZM, Dai DQ. A Novel TNM Classification for Colorectal Cancers based on the Metro-ticket Paradigm. J Cancer 2021;12:3299-306. [PMID: 33976739 DOI: 10.7150/jca.55097] [Reference Citation Analysis]
182 Feng JF, Huang Y, Zhao Q. Tumor length in elderly patients with esophageal squamous cell carcinoma: is it a prognostic factor? Ups J Med Sci. 2013;118:145-152. [PMID: 23617771 DOI: 10.3109/03009734.2013.792887] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
183 Pei JP, Zhang CD, Liang Y, Zhang C, Wu KZ, Li YZ, Zhao ZM, Dai DQ. A Modified Pathological N Stage Including Status of Tumor Deposits in Colorectal Cancer With Nodal Metastasis. Front Oncol 2020;10:548692. [PMID: 33262940 DOI: 10.3389/fonc.2020.548692] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
184 Xu Y, Jiang Y, Yu X, Chen Q, Zhou X, Mao W. Analysis of new N-category on prognosis of oesophageal cancer with positive lymph nodes in a Chinese population. Radiol Oncol 2013;47:63-70. [PMID: 23450452 DOI: 10.2478/v10019-012-0039-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
185 Wang L, Wang L, Wang X, Shang D, Yin S, Sun L, Ji H. MicroRNA-218 inhibits the proliferation, migration, and invasion and promotes apoptosis of gastric cancer cells by targeting LASP1. Tumor Biol 2016;37:15241-52. [DOI: 10.1007/s13277-016-5388-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
186 Sun Z, Liu X, Song JH, Cheng Y, Liu Y, Jia Y, Meltzer SJ, Wang Z. TNFAIP8 overexpression: a potential predictor of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor Lewis esophagectomy. Tumour Biol. 2016;37:10923-10934. [PMID: 26886285 DOI: 10.1007/s13277-016-4978-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
187 Nomura M, Shitara K, Kodaira T, Kondoh C, Takahari D, Ura T, Kojima H, Kamata M, Muro K, Sawada S. Recursive partitioning analysis for new classification of patients with esophageal cancer treated by chemoradiotherapy. Int J Radiat Oncol Biol Phys 2012;84:786-92. [PMID: 22414283 DOI: 10.1016/j.ijrobp.2011.12.069] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
188 Zhang J, Chen S, Gu J, Zhu Y, Zhan Q, Cheng D, Chen H, Deng X, Shen B, Peng C. Retracted: MicroRNA‐300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial‐mesenchymal transition via the Wnt/β‐catenin signaling pathway by targeting CUL4B in pancreatic cancer cells. J Cell Biochem 2018;119:1027-40. [DOI: 10.1002/jcb.26270] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
189 van Rossum PS, van Hillegersberg R, Lever FM, Lips IM, van Lier AL, Meijer GJ, van Leeuwen MS, van Vulpen M, Ruurda JP. Imaging strategies in the management of oesophageal cancer: what's the role of MRI? Eur Radiol. 2013;23:1753-1765. [PMID: 23404138 DOI: 10.1007/s00330-013-2773-6] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 5.4] [Reference Citation Analysis]
190 Kim JY, Nelson RA, Kim J, Raz D. How well does pathologic stage predict survival for esophageal adenocarcinoma after neoadjuvant therapy? J Thorac Dis 2015;7:734-9. [PMID: 25973240 DOI: 10.3978/j.issn.2072-1439.2015.04.30] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
191 Feng JF, Wang L, Yang X, Chen S. Gustave Roussy Immune Score (GRIm-Score) is a prognostic marker in patients with resectable esophageal squamous cell carcinoma. J Cancer 2020;11:1334-40. [PMID: 32047540 DOI: 10.7150/jca.37898] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
192 Feng JF, Zhao Q, Chen QX. Prognostic significance of Glasgow prognostic score in patients undergoing esophagectomy for esophageal squamous cell carcinoma. Saudi J Gastroenterol 2014;20:48-53. [PMID: 24496158 DOI: 10.4103/1319-3767.126319] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
193 Liu H, Lu L, Zhu Q, Hao Y, Mo Y, Liu M, Hu Y, Cui N, Rong T. Cervical nodal metastases of unresectable thoracic esophageal squamous cell carcinoma: characteristics of long-term survivors after concurrent chemoradiotherapy. Radiother Oncol 2011;99:181-6. [PMID: 21620504 DOI: 10.1016/j.radonc.2011.05.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
194 Hatta W, Tong D, Lee YY, Ichihara S, Uedo N, Gotoda T. Different time trend and management of esophagogastric junction adenocarcinoma in three Asian countries. Dig Endosc 2017;29 Suppl 2:18-25. [PMID: 28425657 DOI: 10.1111/den.12808] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 5.8] [Reference Citation Analysis]
195 Manilich EA, Kiran RP, Radivoyevitch T, Lavery I, Fazio VW, Remzi FH. A novel data-driven prognostic model for staging of colorectal cancer. J Am Coll Surg 2011; 213: 579-588, 588.e1-588. e2. [PMID: 21925905 DOI: 10.1016/j.jamcollsurg.2011.08.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
196 Speicher PJ, Ganapathi AM, Englum BR, Hartwig MG, Onaitis MW, D'Amico TA, Berry MF. Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer. J Thorac Oncol 2014;9:1195-201. [PMID: 25157773 DOI: 10.1097/JTO.0000000000000228] [Cited by in Crossref: 43] [Cited by in F6Publishing: 20] [Article Influence: 6.1] [Reference Citation Analysis]
197 Rusch VW, Rice TW, Crowley J, Blackstone EH, Rami-Porta R, Goldstraw P. The seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Staging Manuals: the new era of data-driven revisions. J Thorac Cardiovasc Surg. 2010;139:819-821. [PMID: 20304130 DOI: 10.1016/j.jtcvs.2010.02.013] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
198 Li Z, Rice TW. Diagnosis and staging of cancer of the esophagus and esophagogastric junction. Surg Clin North Am. 2012;92:1105-1126. [PMID: 23026272 DOI: 10.1016/j.suc.2012.07.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
199 Rice TW. 7th Edition AJCC/UICC Staging: Esophagus and Esophagogastric Junction. In: Giacopuzzi S, Zanoni A, de Manzoni G, editors. Adenocarcinoma of the Esophagogastric Junction. Cham: Springer International Publishing; 2017. pp. 41-6. [DOI: 10.1007/978-3-319-28776-8_6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
200 Nafteux PR, Lerut AM, Moons J, Hölscher AH, Bollschweiler E, van Berge Henegouwen MI, Lagarde SM, van Lanschot JJ, Messager M, Mariette C, D'Journo XB, Thomas PA, De Leyn PR. International Multicenter Study on the Impact of Extracapsular Lymph Node Involvement in Primary Surgery Adenocarcinoma of the Esophagus on Overall Survival and Staging Systems. Ann Surg 2015;262:809-15; discussion 815-6. [PMID: 26583670 DOI: 10.1097/SLA.0000000000001463] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
201 Shu P, Qin J, Shen K, Chen W, Liu F, Fang Y, Wang X, Wang H, Shen Z, Sun Y, Qin X. The IGCA staging system is more accurate than AJCC7 system in stratifying survival of patients with gastric cancer in stage III. BMC Cancer 2017;17:238. [PMID: 28359303 DOI: 10.1186/s12885-017-3235-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
202 Shapiro J, Biermann K, van Klaveren D, Offerhaus GJ, Ten Kate FJ, Meijer SL, van Berge Henegouwen MI, Steyerberg EW, Wijnhoven BP, Lanschot JJ. Prognostic Value of Pretreatment Pathological Tumor Extent in Patients Treated With Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal or Junctional Cancer. Ann Surg 2017;265:356-62. [PMID: 28059964 DOI: 10.1097/SLA.0000000000001630] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
203 Manilich E, Remzi FH, Fazio VW, Church JM, Kiran RP. Prognostic modeling of preoperative risk factors of pouch failure. Dis Colon Rectum. 2012;55:393-399. [PMID: 22426262 DOI: 10.1097/dcr.0b013e3182452594] [Cited by in Crossref: 33] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
204 Yoon HH, Khan M, Shi Q, Cassivi SD, Wu TT, Quevedo JF, Burch PA, Sinicrope FA, Diasio RB. The prognostic value of clinical and pathologic factors in esophageal adenocarcinoma: a mayo cohort of 796 patients with extended follow-up after surgical resection. Mayo Clin Proc. 2010;85:1080-1089. [PMID: 21123634 DOI: 10.4065/mcp.2010.0421] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
205 Worni M, Castleberry AW, Gloor B, Pietrobon R, Haney JC, D'Amico TA, Akushevich I, Berry MF. Trends and outcomes in the use of surgery and radiation for the treatment of locally advanced esophageal cancer: a propensity score adjusted analysis of the surveillance, epidemiology, and end results registry from 1998 to 2008. Dis Esophagus 2014;27:662-9. [PMID: 23937253 DOI: 10.1111/dote.12123] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
206 Sun HB, Li Y, Liu XB, Zhang RX, Wang ZF, Lerut T, Liu CC, Fiorelli A, Chao YK, Molena D, Cerfolio RJ, Ozawa S, Chang AC; written on behalf of the AME Thoracic Surgery Collaborative Group. Early Oral Feeding Following McKeown Minimally Invasive Esophagectomy: An Open-label, Randomized, Controlled, Noninferiority Trial. Ann Surg 2018;267:435-42. [PMID: 28549015 DOI: 10.1097/SLA.0000000000002304] [Cited by in Crossref: 48] [Cited by in F6Publishing: 20] [Article Influence: 16.0] [Reference Citation Analysis]
207 Hsich EM, Thuita L, McNamara DM, Rogers JG, Valapour M, Goldberg LR, Yancy CW, Blackstone EH, Ishwaran H; Transplantation of HEarts to MaxImize Survival (THEMIS) Investigators. Variables of importance in the Scientific Registry of Transplant Recipients database predictive of heart transplant waitlist mortality. Am J Transplant 2019;19:2067-76. [PMID: 30659754 DOI: 10.1111/ajt.15265] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
208 Pei JP, Zhang CD, Fan YC, Dai DQ. Comparison of Different Lymph Node Staging Systems in Patients With Resectable Colorectal Cancer. Front Oncol. 2018;8:671. [PMID: 30697530 DOI: 10.3389/fonc.2018.00671] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
209 Martin JT, Worni M, Zwischenberger JB, Gloor B, Pietrobon R, D'Amico TA, Berry MF. The role of radiation therapy in resected T2 N0 esophageal cancer: a population-based analysis. Ann Thorac Surg 2013;95:453-8. [PMID: 23063200 DOI: 10.1016/j.athoracsur.2012.08.049] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
210 Thomaschewski M, Hummel R, Petrova E, Knief J, Wellner UF, Keck T, Bausch D. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours. World J Gastroenterol 2018; 24(13): 1429-1439 [PMID: 29632424 DOI: 10.3748/wjg.v24.i13.1429] [Reference Citation Analysis]
211 Gao YB, Chen ZL, Li JG, Hu XD, Shi XJ, Sun ZM, Zhang F, Zhao ZR, Li ZT, Liu ZY, Zhao YD, Sun J, Zhou CC, Yao R, Wang SY, Wang P, Sun N, Zhang BH, Dong JS, Yu Y, Luo M, Feng XL, Shi SS, Zhou F, Tan FW, Qiu B, Li N, Shao K, Zhang LJ, Zhang LJ, Xue Q, Gao SG, He J. Genetic landscape of esophageal squamous cell carcinoma. Nat Genet 2014;46:1097-102. [PMID: 25151357 DOI: 10.1038/ng.3076] [Cited by in Crossref: 343] [Cited by in F6Publishing: 362] [Article Influence: 42.9] [Reference Citation Analysis]
212 Wu SG, Sun JY, Yang LC, Zhou J, Li FY, Li Q, Lin HX, Lin Q, He ZY. Prognosis of patients with esophageal squamous cell carcinoma after esophagectomy using the log odds of positive lymph nodes. Oncotarget 2015;6:36911-22. [PMID: 26426993 DOI: 10.18632/oncotarget.5366] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
213 D'Journo XB. Clinical implication of the innovations of the 8th edition of the TNM classification for esophageal and esophago-gastric cancer. J Thorac Dis 2018;10:S2671-81. [PMID: 30345104 DOI: 10.21037/jtd.2018.03.182] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
214 Yu W, Chu L, Zhao K, Chen H, Xiang J, Zhang Y, Li H, Zhao W, Sun M, Wei Q, Fu X, Xie C, Zhu Z. A nomogram based on phosphorylated AKT1 for predicting locoregional recurrence in patients with oesophageal squamous cell carcinoma. J Cancer 2017;8:3755-63. [PMID: 29151963 DOI: 10.7150/jca.20828] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
215 Chen S, Yang X, Feng JF. A novel inflammation-based prognostic score for patients with esophageal squamous cell carcinoma: the c-reactive protein/prognostic nutritional index ratio. Oncotarget 2016;7:62123-32. [PMID: 27557504 DOI: 10.18632/oncotarget.11389] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
216 Davison JM, Landau MS, Luketich JD, McGrath KM, Foxwell TJ, Landsittel DP, Gibson MK, Nason KS. A Model Based on Pathologic Features of Superficial Esophageal Adenocarcinoma Complements Clinical Node Staging in Determining Risk of Metastasis to Lymph Nodes. Clin Gastroenterol Hepatol 2016;14:369-377.e3. [PMID: 26515637 DOI: 10.1016/j.cgh.2015.10.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
217 Hong X, Yu JJ. MicroRNA-150 suppresses epithelial-mesenchymal transition, invasion, and metastasis in prostate cancer through the TRPM4-mediated β-catenin signaling pathway. Am J Physiol Cell Physiol 2019;316:C463-80. [PMID: 30566393 DOI: 10.1152/ajpcell.00142.2018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
218 Wu SG, He ZY, Wang Y, Sun JY, Lin HX, Su GQ, Li Q. Lymph node dissection improved survival in patients with metastatic thoracic esophageal cancer: An analysis of 220 patients from the SEER database. Int J Surg 2016;35:13-8. [PMID: 27613123 DOI: 10.1016/j.ijsu.2016.09.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
219 Gao HJ, Wei YC, Gong L, Ge N, Han B, Shi GD, Yu ZT. Role of radiation therapy in node-negative esophageal cancer: A propensity-matched analysis. Thorac Cancer 2020;11:2820-9. [PMID: 32790041 DOI: 10.1111/1759-7714.13607] [Reference Citation Analysis]
220 Xu Y, Chen Q, Yu X, Zhou X, Zheng X, Mao W. Factors influencing the risk of recurrence in patients with esophageal carcinoma treated with surgery: A single institution analysis consisting of 1002 cases. Oncol Lett. 2013;5:185-190. [PMID: 23255917 DOI: 10.3892/ol.2012.1007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
221 Wu SG, Dai MM, He ZY, Sun JY, Lin HX, Lin H, Li Q. Patterns of Regional Lymph Node Recurrence After Radical Surgery for Thoracic Esophageal Squamous Cell Carcinoma. Ann Thorac Surg 2016;101:551-7. [PMID: 26530541 DOI: 10.1016/j.athoracsur.2015.08.057] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
222 Nomura M, Kato K, Ando N, Ohtsu A, Muro K, Igaki H, Abe T, Takeuchi H, Daiko H, Gotoh M, Kataoka K, Wakabayashi M, Kitagawa Y. Comparison between neoadjuvant chemotherapy followed by surgery and definitive chemoradiotherapy for overall survival in patients with clinical Stage II/III esophageal squamous cell carcinoma (JCOG1406-A). Jpn J Clin Oncol 2017;47:480-6. [PMID: 28334858 DOI: 10.1093/jjco/hyx040] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
223 Tachimori Y, Ozawa S, Numasaki H, Matsubara H, Shinoda M, Toh Y, Udagawa H; Registration Committee for Esophageal Cancer of the Japan Esophageal Society. Supraclavicular node metastasis from thoracic esophageal carcinoma: A surgical series from a Japanese multi-institutional nationwide registry of esophageal cancer. J Thorac Cardiovasc Surg 2014;148:1224-9. [PMID: 24613171 DOI: 10.1016/j.jtcvs.2014.02.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
224 Zhao LY, Zhao YL, Wang JJ, Zhao QD, Yi WQ, Yuan Q, Chen XZ, Li Y, Yang K, Chen XL, Zhang WH, Liu K, Pang HY, Galiullin D, Wang H, Sun LF, Song XH, Zheng JB, Yao XQ, Zhou ZG, Yu PW, Hu JK. Is Preoperative Fibrinogen Associated with the Survival Prognosis of Gastric Cancer Patients? A Multi-centered, Propensity Score-Matched Retrospective Study. World J Surg 2020;44:213-22. [PMID: 31637507 DOI: 10.1007/s00268-019-05191-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
225 Yang H, Hou X, Liu Q, Zhang L, Liu J, Lin P, Fu J. Tumor Location Does Not Impact Long-Term Survival in Patients With Operable Thoracic Esophageal Squamous Cell Carcinoma in China. The Annals of Thoracic Surgery 2012;93:1861-6. [DOI: 10.1016/j.athoracsur.2012.03.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
226 Rice TW, Ishwaran H, Kelsen DP, Hofstetter WL, Apperson-Hansen C, Blackstone EH; Worldwide Esophageal Cancer Collaboration Investigators. Recommendations for neoadjuvant pathologic staging (ypTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus. 2016;29:906-912. [PMID: 27905170 DOI: 10.1111/dote.12538] [Cited by in Crossref: 34] [Cited by in F6Publishing: 42] [Article Influence: 6.8] [Reference Citation Analysis]
227 Foley KG, Powell A, Lewis WG, Roberts SA. The 100 most cited articles investigating the radiological staging of oesophageal and junctional cancer: a bibliometric analysis. Insights Imaging 2016;7:619-28. [PMID: 27278388 DOI: 10.1007/s13244-016-0505-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
228 Akutsu Y, Yasuda S, Nagata M, Izumi Y, Okazumi S, Shimada H, Nakatani Y, Tsujii H, Kamada T, Yamada S, Matsubara H. A phase I/II clinical trial of preoperative short-course carbon-ion radiotherapy for patients with squamous cell carcinoma of the esophagus: Carbon-Ion Therapy for Esophageal Cancer. J Surg Oncol 2012;105:750-5. [DOI: 10.1002/jso.22127] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
229 Takeno S, Takahashi Y, Hashimoto T, Maki K, Shibata R, Yamana I, Sasaki T, Yoshida Y, Shiwaku H, Yamashita K, Aisu N, Yamashita Y, Moroga T, Ono K, Kawahara K. Is the prognostic impact of tumor location in patients with surgically resected esophageal squamous cell carcinoma affected by surgical approach? Eur Surg Res 2013;51:91-8. [PMID: 24157453 DOI: 10.1159/000355680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
230 Boffa DJ. Invited commentary. Ann Thorac Surg 2011;92:224-5. [PMID: 21718848 DOI: 10.1016/j.athoracsur.2011.04.098] [Reference Citation Analysis]
231 Collazo S, Graf NL. A System-Based Nursing Approach to Improve Outcomes in the Postoperative Esophagectomy Patient. Seminars in Oncology Nursing 2017;33:37-51. [DOI: 10.1016/j.soncn.2016.11.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
232 Depypere L, Moons J, Lerut T, De Hertogh G, Sagaert X, Coosemans W, Van Veer H, Renders A, Nafteux P. Neoadjuvant chemoradiation treatment followed by surgery for esophageal cancer: there is much more than the mandard tumor regression score. Acta Chir Belg 2016;116:149-55. [PMID: 27472306 DOI: 10.1080/00015458.2016.1212500] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
233 Wahed S, Michael Griffin S. Poorer Survival for Stage IIa Patients After Minimally Invasive Esophagectomy. Ann Surg 2015;262:e45. [PMID: 24670854 DOI: 10.1097/SLA.0000000000000532] [Reference Citation Analysis]
234 Giles AE, Kidane B. Bridging the gap: how do we improve long-term survival of locally-advanced esophageal cancer patients? J Thorac Dis 2019;11:S1841-3. [PMID: 31632764 DOI: 10.21037/jtd.2019.08.112] [Reference Citation Analysis]
235 Dreikhausen L, Blank S, Sisic L, Heger U, Weichert W, Jäger D, Bruckner T, Giese N, Grenacher L, Falk C, Ott K, Schmidt T. Association of angiogenic factors with prognosis in esophageal cancer. BMC Cancer 2015;15:121. [PMID: 25885021 DOI: 10.1186/s12885-015-1120-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
236 McNamara MJ, Rybicki LA, Sohal D, Allende DS, Videtic GM, Rodriguez CP, Stephans KL, Murthy SC, Raja S, Raymond D, Ives DI, Bodmann JW, Adelstein DJ. The relationship between pathologic nodal disease and residual tumor viability after induction chemotherapy in patients with locally advanced esophageal adenocarcinoma receiving a tri-modality regimen. J Gastrointest Oncol 2016;7:196-205. [PMID: 27034786 DOI: 10.3978/j.issn.2078-6891.2015.097] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
237 Huang Q. Carcinoma of the gastroesophageal junction in Chinese patients. World J Gastroenterol 2012; 18(48): 7134-7140 [PMID: 23326117 DOI: 10.3748/wjg.v18.i48.7134] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
238 Järvinen T, Ilonen I, Ylikoski E, Nelskylä K, Kauppi J, Salo J, Räsänen J. Preoperative stenting in oesophageal cancer has no effect on survival: a propensity-matched case-control study†. European Journal of Cardio-Thoracic Surgery 2017;52:385-91. [DOI: 10.1093/ejcts/ezx097] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
239 Deng HY, Ni PZ, Wang YC, Wang WP, Chen LQ. Neuroendocrine carcinoma of the esophagus: clinical characteristics and prognostic evaluation of 49 cases with surgical resection. J Thorac Dis. 2016;8:1250-1256. [PMID: 27293844 DOI: 10.21037/jtd.2016.04.21] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 4.2] [Reference Citation Analysis]
240 van der Horst S, Weijs TJ, Ruurda JP, Haj Mohammad N, Mook S, Brosens LAA, van Hillegersberg R. Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy for esophageal cancer in the upper mediastinum. J Thorac Dis 2017;9:S834-42. [PMID: 28815081 DOI: 10.21037/jtd.2017.03.151] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
241 Zaninotto G, Hunter JG. Dysplastic Barrett's esophagus. World J Surg 2015;39:557-8. [PMID: 25002243 DOI: 10.1007/s00268-014-2681-1] [Reference Citation Analysis]
242 Stahl M, Mariette C, Haustermans K, Cervantes A, Arnold D; ESMO Guidelines Working Group. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24 Suppl 6:vi51-vi56. [PMID: 24078662 DOI: 10.1093/annonc/mdt342] [Cited by in Crossref: 131] [Cited by in F6Publishing: 126] [Article Influence: 16.4] [Reference Citation Analysis]
243 Kleinberg L. Therapy for locally advanced adenocarcinoma of the gastroesophageal junction: optimizing outcome. Semin Radiat Oncol. 2013;23:38-50. [PMID: 23207046 DOI: 10.1016/j.semradonc.2012.10.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
244 Li S, Li B, Wang J, Zhang D, Liu Z, Zhang Z, Zhang W, Wang Y, Bai D, Guan J. Identification of Sensitivity Predictors of Neoadjuvant Chemotherapy for the Treatment of Adenocarcinoma of Gastroesophageal Junction. Oncol Res. 2017;25:93-97. [PMID: 28081737 DOI: 10.3727/096504016x14719078133564] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
245 Feng JF, Huang Y, Chen QX. The combination of platelet count and neutrophil lymphocyte ratio is a predictive factor in patients with esophageal squamous cell carcinoma. Transl Oncol 2014;7:632-7. [PMID: 25389458 DOI: 10.1016/j.tranon.2014.07.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
246 Liu Y, Yang H, Fu H, Li M, Feng Z, Peng Z, Liang Z, Wang H. Prognostic impact of examined lymph node count in pT1N0M0 esophageal cancer: A population-based study. Thorac Cancer 2019;10:1636-43. [PMID: 31237106 DOI: 10.1111/1759-7714.13130] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
247 Cummings Iii KC, Kou TD, Chak A, Schluchter MD, Margevicius S, Cooper GS, Meropol NJ, Perry Y, Linden PA, Cummings LC. Surgical approach and the impact of epidural analgesia on survival after esophagectomy for cancer: A population-based retrospective cohort study. PLoS One 2019;14:e0211125. [PMID: 30668599 DOI: 10.1371/journal.pone.0211125] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
248 So B, Marcu L, Olver I, Gowda R, Bezak E. Oesophageal cancer: Which treatment is the easiest to swallow? A review of combined modality treatments for resectable carcinomas. Crit Rev Oncol Hematol 2017;113:135-50. [PMID: 28427503 DOI: 10.1016/j.critrevonc.2017.03.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
249 Liu Z, Gao P, Liu S, Zheng G, Yang J, Sun L, Hong L, Fan D, Zhang H, Feng F. Tumor volume increases the predictive accuracy of prognosis for gastric cancer: A retrospective cohort study of 3409 patients. Oncotarget. 2017;8:18968-18978. [PMID: 28145885 DOI: 10.18632/oncotarget.14859] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
250 Chen PC, Feng JF. A Novel Inflammation-Based Stage (I Stage) in Patients with Resectable Esophageal Squamous Cell Carcinoma. Mediators Inflamm 2016;2016:5396747. [PMID: 27212808 DOI: 10.1155/2016/5396747] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
251 Wei Y, Wu S, Shi D, Dou S, Sun T, Ning P, Zhao C, Li Z, Li X, Gao F, Li L, Zheng D, Zhu S. Oesophageal carcinoma: comparison of ex vivo high-resolution 3.0 T MR imaging with histopathological findings. Sci Rep 2016;6:35109. [PMID: 27725771 DOI: 10.1038/srep35109] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
252 Rice TW, Apperson-Hansen C, DiPaola LM, Semple ME, Lerut TE, Orringer MB, Chen LQ, Hofstetter WL, Smithers BM, Rusch VW, Wijnhoven BP, Chen KN, Davies AR, D'Journo XB, Kesler KA, Luketich JD, Ferguson MK, Räsänen JV, van Hillegersberg R, Fang W, Durand L, Allum WH, Cecconello I, Cerfolio RJ, Pera M, Griffin SM, Burger R, Liu JF, Allen MS, Law S, Watson TJ, Darling GE, Scott WJ, Duranceau A, Denlinger CE, Schipper PH, Ishwaran H, Blackstone EH. Worldwide Esophageal Cancer Collaboration: clinical staging data. Dis Esophagus 2016;29:707-14. [PMID: 27731549 DOI: 10.1111/dote.12493] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 12.2] [Reference Citation Analysis]
253 Cartwright E, Cunningham D. The Role of Systemic Therapy in Resectable Gastric and Gastro-oesophageal Junction Cancer. Curr Treat Options Oncol 2017;18:69. [PMID: 29143893 DOI: 10.1007/s11864-017-0510-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
254 Stahl M, Lehmann N, Walz MK, Stuschke M, Wilke H. Prediction of prognosis after trimodal therapy in patients with locally advanced squamous cell carcinoma of the oesophagus. European Journal of Cancer 2012;48:2977-82. [DOI: 10.1016/j.ejca.2012.03.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
255 Yasuda T, Yano M, Miyata H, Yamasaki M, Higuchi I, Takiguchi S, Fujiwara Y, Doki Y. Systemic control and evaluation of the response to neoadjuvant chemotherapy in resectable thoracic esophageal squamous cell carcinoma with 18F-fluorodeoxyglucose positron emission tomography-positive lymph nodes. Surg Today 2015;45:335-45. [DOI: 10.1007/s00595-014-0956-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
256 Wang T, Lv X, Jiang S, Han S, Wang Y. Expression of ADAM29 and FAM135B in the pathological evolution from normal esophageal epithelium to esophageal cancer: Their differences and clinical significance. Oncol Lett 2020;19:1727-34. [PMID: 32194665 DOI: 10.3892/ol.2020.11272] [Reference Citation Analysis]
257 Berry MF. The Role of Induction Therapy for Esophageal Cancer. Thorac Surg Clin 2016;26:295-304. [PMID: 27427524 DOI: 10.1016/j.thorsurg.2016.04.006] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
258 Feng JF, Zhao JM, Chen S, Chen QX. Prognostic Significance of the Lung Immune Prognostic Index in Patients with Resected Esophageal Squamous Cell Carcinoma. Cancer Manag Res 2021;13:2811-9. [PMID: 33814930 DOI: 10.2147/CMAR.S298412] [Reference Citation Analysis]
259 Mulligan CR Jr. Multidisciplinary management of esophageal cancer. Surg Oncol Clin N Am 2013;22:217-46. [PMID: 23453332 DOI: 10.1016/j.soc.2012.12.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
260 Liu K, Feng F, Chen XZ, Zhou XY, Zhang JY, Chen XL, Zhang WH, Yang K, Zhang B, Zhang HW, Zhou ZG, Hu JK. Comparison between gastric and esophageal classification system among adenocarcinomas of esophagogastric junction according to AJCC 8th edition: a retrospective observational study from two high-volume institutions in China. Gastric Cancer 2019;22:506-17. [PMID: 30390154 DOI: 10.1007/s10120-018-0890-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
261 Ning ZH, Pei HL, Ning ZH, Jiang JJ. pN categories based on metastatic lymph node counts are still the cornerstone in operable esophageal cancer. J Thorac Oncol 2015;10:e13. [PMID: 25695226 DOI: 10.1097/JTO.0000000000000458] [Reference Citation Analysis]
262 Hofstetter WL. Invited commentary. Ann Thorac Surg 2012;93:1867. [PMID: 22632488 DOI: 10.1016/j.athoracsur.2012.04.001] [Reference Citation Analysis]
263 Zhu YH, Zhang B, Li M, Huang P, Sun J, Fu J, Guan XY. Prognostic significance of FAM3C in esophageal squamous cell carcinoma. Diagn Pathol 2015;10:192. [PMID: 26498278 DOI: 10.1186/s13000-015-0424-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
264 Wiseman EF, Chen X, Han N, Webber A, Ji Z, Sharrocks AD, Ang YS. Deregulation of the FOXM1 target gene network and its coregulatory partners in oesophageal adenocarcinoma. Mol Cancer 2015;14:69. [PMID: 25889361 DOI: 10.1186/s12943-015-0339-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
265 Wu XJ, Miao RL, Li ZY, Bu ZD, Zhang LH, Wu AW, Zong XL, Li SX, Shan F, Ji X. Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer. Eur J Surg Oncol. 2015;41:927-933. [PMID: 25913059 DOI: 10.1016/j.ejso.2015.03.225] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
266 Ashraf N, Hoffe S, Kim R. Locally advanced gastroesophageal junction tumor: a treatment dilemma. Oncologist 2015;20:134-42. [PMID: 25561508 DOI: 10.1634/theoncologist.2014-0377] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
267 Nomura M, Shitara K, Kodaira T, Hatooka S, Mizota A, Kondoh C, Yokota T, Takahari D, Ura T, Muro K. Prognostic impact of the 6th and 7th American Joint Committee on Cancer TNM staging systems on esophageal cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2012;82:946-952. [PMID: 21362578 DOI: 10.1016/j.ijrobp.2010.12.045] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
268 Ku JW, Zhang DY, Song X, Li XM, Zhao XK, Lv S, Hu SJ, Cheng R, Zhou F, Wu HF, Wang LD. Characterization of tissue chromogranin A (CgA) immunostaining and clinicohistopathological changes for the 125 Chinese patients with primary small cell carcinoma of the esophagus. Diseases of the Esophagus 2017;30:1-7. [DOI: 10.1093/dote/dox041] [Reference Citation Analysis]
269 Berry MF. Esophageal cancer: staging system and guidelines for staging and treatment. J Thorac Dis. 2014;6 Suppl 3:S289-S297. [PMID: 24876933 DOI: 10.3978/j.issn.2072-1439.2014.03.11] [Cited by in F6Publishing: 57] [Reference Citation Analysis]
270 Akutsu Y, Uesato M, Shuto K, Kono T, Hoshino I, Horibe D, Sazuka T, Takeshita N, Maruyama T, Isozaki Y, Akanuma N, Matsubara H. The Overall Prevalence of Metastasis in T1 Esophageal Squamous Cell Carcinoma: A Retrospective Analysis of 295 Patients. Annals of Surgery 2013;257:1032-8. [DOI: 10.1097/sla.0b013e31827017fc] [Cited by in Crossref: 85] [Cited by in F6Publishing: 43] [Article Influence: 9.4] [Reference Citation Analysis]
271 Bauer K, Porzsolt F, Henne-Bruns D. Can perioperative chemotherapy for advanced gastric cancer be recommended on the basis of current research? A critical analysis. J Gastric Cancer. 2014;14:39-46. [PMID: 24765536 DOI: 10.5230/jgc.2014.14.1.39] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
272 Worni M, Martin J, Gloor B, Pietrobon R, D'Amico TA, Akushevich I, Berry MF. Does surgery improve outcomes for esophageal squamous cell carcinoma? An analysis using the surveillance epidemiology and end results registry from 1998 to 2008. J Am Coll Surg 2012;215:643-51. [PMID: 23084493 DOI: 10.1016/j.jamcollsurg.2012.07.006] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 3.9] [Reference Citation Analysis]
273 Langer R, Becker K, Zlobec I, Gertler R, Sisic L, Büchler M, Lordick F, Slotta-Huspenina J, Weichert W, Höfler H, Feith M, Ott K. A multifactorial histopathologic score for the prediction of prognosis of resected esophageal adenocarcinomas after neoadjuvant chemotherapy. Ann Surg Oncol 2014;21:915-21. [PMID: 24281419 DOI: 10.1245/s10434-013-3410-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
274 Tekola BD, Sauer BG, Wang AY, White GE, Shami VM. Accuracy of endoscopic ultrasound in the diagnosis of T2N0 esophageal cancer. J Gastrointest Cancer. 2014;45:342-346. [PMID: 24788081 DOI: 10.1007/s12029-014-9616-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
275 Tóth D, Bíró A, Varga Z, Török M, Árkosy P. Comparison of different lymph node staging systems in prognosis of gastric cancer: a bi-institutional study from Hungary. Chin J Cancer Res 2017;29:323-32. [PMID: 28947864 DOI: 10.21147/j.issn.1000-9604.2017.04.05] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
276 Chak A, Chen Y, Vengoechea J, Canto MI, Elston R, Falk GW, Grady WM, Guda K, Kinnard M, Markowitz S, Mittal S, Prasad G, Shaheen N, Willis JE, Barnholtz-Sloan JS. Variation in age at cancer diagnosis in familial versus nonfamilial Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2012;21:376-83. [PMID: 22178570 DOI: 10.1158/1055-9965.EPI-11-0927] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
277 Welsh J, Amini A, Likhacheva A, Erasmus J J, Gomez D, Davila M, Mehran RJ, Komaki R, Liao Z, Hofstetter WL, Lee H J, Bhutani MS, Ajani JA. Update: modern approaches to the treatment of localized esophageal cancer. Curr Oncol Rep 2011;13:157-67. [PMID: 21365188 DOI: 10.1007/s11912-011-0158-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
278 Hatogai K, Fujii S, Kojima T, Daiko H, Kadota T, Fujita T, Yoshino T, Doi T, Takiguchi Y, Ohtsu A. Prognostic significance of tumor regression grade for patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgery. J Surg Oncol 2016;113:390-6. [PMID: 27100024 DOI: 10.1002/jso.24151] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
279 Li S, Wang Z, Huang J, Cheng S, Du H, Che G, Peng Y. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis. BMC Cancer 2016;16:877. [PMID: 27835987 DOI: 10.1186/s12885-016-2940-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
280 Wei Y, Wu S, Gao F, Sun T, Zheng D, Ning P, Zhao C, Li Z, Li X, Li L, Zhu S. Esophageal carcinoma: Ex vivo evaluation by high-spatial-resolution T2 -mapping MRI compared with histopathological findings at 3.0T. J Magn Reson Imaging 2017;45:1609-16. [PMID: 27711986 DOI: 10.1002/jmri.25509] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
281 Smyth EC, Lagergren J, Fitzgerald RC, Lordick F, Shah MA, Lagergren P, Cunningham D. Oesophageal cancer. Nat Rev Dis Primers. 2017;3:17048. [PMID: 28748917 DOI: 10.1038/nrdp.2017.48] [Cited by in Crossref: 249] [Cited by in F6Publishing: 246] [Article Influence: 49.8] [Reference Citation Analysis]
282 Sherman SK, Maxwell JE, Qian Q, Bellizzi AM, Braun TA, Iannettoni MD, Darbro BW, Howe JR. Esophageal cancer in a family with hamartomatous tumors and germline PTEN frameshift and SMAD7 missense mutations. Cancer Genet 2015;208:41-6. [PMID: 25554686 DOI: 10.1016/j.cancergen.2014.11.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
283 Curtis NJ, Noble F, Bailey IS, Kelly JJ, Byrne JP, Underwood TJ. The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction. J Surg Oncol. 2014;109:202-207. [PMID: 24243140 DOI: 10.1002/jso.23484] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
284 Lu J, Tao H, Song D, Chen C. Recurrence risk model for esophageal cancer after radical surgery. Chin J Cancer Res 2013;25:549-55. [PMID: 24255579 DOI: 10.3978/j.issn.1000-9604.2013.10.05] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
285 Wang L, Dong G, Xia W, Mao Q, Wang A, Chen B, Ma W, Wu Y, Xu L, Jiang F. Integrative analysis of differential genes and identification of a "2-gene score" associated with survival in esophageal squamous cell carcinoma. Thorac Cancer 2019;10:60-70. [PMID: 30421504 DOI: 10.1111/1759-7714.12902] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
286 Bharat A, Crabtree T. Management of advanced-stage operable esophageal cancer. Surg Clin North Am 2012;92:1179-97. [PMID: 23026277 DOI: 10.1016/j.suc.2012.07.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
287 Davison JM, Yee M, Krill-Burger JM, Lyons-Weiler MA, Kelly LA, Sciulli CM, Nason KS, Luketich JD, Michalopoulos GK, LaFramboise WA. The degree of segmental aneuploidy measured by total copy number abnormalities predicts survival and recurrence in superficial gastroesophageal adenocarcinoma. PLoS One 2014;9:e79079. [PMID: 24454681 DOI: 10.1371/journal.pone.0079079] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
288 Sun SY, Chen PP, Meng LX, Li L, Mo ZX, Sun CH, Wang Y, Liang FH. High preoperative plasma fibrinogen and serum albumin score is associated with poor survival in operable esophageal squamous cell carcinoma. Dis Esophagus 2019;32. [PMID: 29905761 DOI: 10.1093/dote/doy057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
289 Hayashi T, Yoshikawa T, Bonam K, Sue-ling HM, Taguri M, Morita S, Tsuburaya A, Hayden JD, Grabsch HI. The superiority of the seventh edition of the TNM classification depends on the overall survival of the patient cohort: Comparative analysis of the sixth and seventh TNM editions in patients with gastric cancer from Japan and the United Kingdom. Cancer 2013;119:1330-7. [DOI: 10.1002/cncr.27928] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
290 Zhao Q, Li Y, Wang J, Zhang J, Qiao X, Tan B, Tian Y, Shi G, Xu Q, Li R, Liu Y, Yang P. Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal Junction. Am J Med Sci 2015;349:472-6. [PMID: 25996101 DOI: 10.1097/MAJ.0000000000000476] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
291 Sakin A, Alay M, Sahin S, Aydemir O, Aldemir MN, Sakin A, Kotan C. Prognostic significance of neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma. North Clin Istanb 2021;8:435-42. [PMID: 34909581 DOI: 10.14744/nci.2020.63004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
292 Wittekind C. The development of the TNM classification of gastric cancer. Pathol Int. 2015;65:399-403. [PMID: 26036980 DOI: 10.1111/pin.12306] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
293 Peng J, Wang W, Dong T, Cai J, Ni P, Chen L. Refining the Nodal Staging for Esophageal Squamous Cell Carcinoma Based on Lymph Node Stations. The Annals of Thoracic Surgery 2016;101:280-6. [DOI: 10.1016/j.athoracsur.2015.06.081] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
294 Li S, Rau K, Lu H, Wang Y, Tien W, Liang J, Lin W. Pre-treatment maximal oesophageal wall thickness is independently associated with response to chemoradiotherapy in patients with T3-4 oesophageal squamous cell carcinoma. European Journal of Cardio-Thoracic Surgery 2012;42:958-64. [DOI: 10.1093/ejcts/ezs136] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
295 Wang N, Li X, Luo H, Sun Y, Zheng X, Fan C, Wang H, Ye K, Ge H. Prognostic value of pretreatment inflammatory biomarkers in primary small cell carcinoma of the esophagus. Thorac Cancer. 2019;10:1913-1918. [PMID: 31389159 DOI: 10.1111/1759-7714.13164] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
296 Zhang X, Yu J, Li M, Zhu H. Details of out-field regional recurrence after involved-field irradiation with concurrent chemotherapy for locally advanced esophageal squamous cell carcinoma. Onco Targets Ther 2016;9:3049-57. [PMID: 27284256 DOI: 10.2147/OTT.S100946] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
297 Hou X, Wei JC, Fu JH, Wang X, Zhang LJ, Lin P, Yang HX. Proposed modification of the seventh American Joint Committee on Cancer staging system for esophageal squamous cell carcinoma in Chinese patients. Ann Surg Oncol 2014;21:337-42. [PMID: 24046121 DOI: 10.1245/s10434-013-3265-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
298 Feng JF, Chen QX. Significance of the prognostic nutritional index in patients with esophageal squamous cell carcinoma. Ther Clin Risk Manag 2014;10:1-7. [PMID: 24379675 DOI: 10.2147/TCRM.S56159] [Cited by in Crossref: 12] [Cited by in F6Publishing: 30] [Article Influence: 1.3] [Reference Citation Analysis]
299 Zahoor H, Luketich JD, Weksler B, Winger DG, Christie NA, Levy RM, Gibson MK, Davison JM, Nason KS. The revised American Joint Committee on Cancer staging system (7th edition) improves prognostic stratification after minimally invasive esophagectomy for esophagogastric adenocarcinoma. Am J Surg 2015;210:610-7. [PMID: 26188709 DOI: 10.1016/j.amjsurg.2015.05.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
300 Mcloughlin JM, Lewis JM, Meredith KL. The Impact of Age on Morbidity and Mortality following Esophagectomy for Esophageal Cancer. Cancer Control 2013;20:144-50. [DOI: 10.1177/107327481302000208] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
301 Cho JW, Choi SC, Jang JY, Shin SK, Choi KD, Lee JH, Kim SG, Sung JK, Jeon SW, Choi IJ, Kim GH, Jee SR, Lee WS, Jung HY; Korean ESD Study Group. Lymph Node Metastases in Esophageal Carcinoma: An Endoscopist's View. Clin Endosc. 2014;47:523-529. [PMID: 25505718 DOI: 10.5946/ce.2014.47.6.523] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 6.6] [Reference Citation Analysis]
302 Jian-Hui C, Shi-Rong C, Hui W, Si-le C, Jian-Bo X, Er-Tao Z, Chuang-Qi C, Yu-Long H. Prognostic value of three different lymph node staging systems in the survival of patients with gastric cancer following D2 lymphadenectomy. Tumour Biol 2016;37:11105-13. [PMID: 26912060 DOI: 10.1007/s13277-015-4191-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
303 Wei XL, Wang FH, Zhang DS, Qiu MZ, Ren C, Jin Y, Zhou YX, Wang DS, He MM, Bai L, Wang F, Luo HY, Li YH, Xu RH. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio. BMC Cancer 2015;15:350. [PMID: 25934640 DOI: 10.1186/s12885-015-1379-6] [Cited by in Crossref: 85] [Cited by in F6Publishing: 97] [Article Influence: 12.1] [Reference Citation Analysis]
304 Boniface MM, Wani SB, Schefter TE, Koo PJ, Meguid C, Leong S, Kaplan JB, Wingrove LJ, McCarter MD. Multidisciplinary management for esophageal and gastric cancer. Cancer Manag Res. 2016;8:39-44. [PMID: 27217796 DOI: 10.2147/CMAR.S101169] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
305 Old OJ, Isabelle M, Barr H. Staging Early Esophageal Cancer. Adv Exp Med Biol 2016;908:161-81. [PMID: 27573772 DOI: 10.1007/978-3-319-41388-4_9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
306 Mine S, Watanabe M, Imamura Y, Okamura A, Kurogochi T, Sano T. Clinical Significance of the Pre-therapeutic Nodal Size in Patients Undergoing Neo-Adjuvant Treatment Followed by Esophagectomy for Esophageal Squamous Cell Carcinoma. World J Surg 2017;41:184-90. [PMID: 27468743 DOI: 10.1007/s00268-016-3675-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
307 Yu Y, Huang C, Li Z, Zhao F, Zhou Y, Li J, Zhu C, Li Q, Zhuang Y, Xu J, Luo J, Chen L, Wang W. Expressions of melanoma-associated antigen A1 as a prognostic factor in Chinese patients with resectable oesophageal squamous cell carcinoma. Interactive CardioVascular and Thoracic Surgery 2019;29:510-6. [DOI: 10.1093/icvts/ivz141] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
308 Villalabeitia Ateca I, Perfecto Valero A, Serrano Hermosilla C, Marcaida Salazar A, Pérez Fernández S, Sarriugarte Lasarte A. Prognostic value of the nodal ratio in gastric cancer: Unicentric analysis pf 199 patients. Cir Esp (Engl Ed) 2021:S0009-739X(21)00131-7. [PMID: 33896606 DOI: 10.1016/j.ciresp.2021.03.018] [Reference Citation Analysis]
309 Ren Y, Ye J, Xiong W, Zuo J, He Y, Tan M, Yuan Y. Adjuvant radiotherapy for positive lymph nodes of oesophageal squamous cell carcinoma: Can it earn promising benefits at long-term follow-up? Cancer Radiother 2018;22:140-7. [PMID: 29454737 DOI: 10.1016/j.canrad.2017.09.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
310 Mehta K, Bianco V, Awais O, Luketich JD, Pennathur A. Minimally invasive staging of esophageal cancer. Ann Cardiothorac Surg. 2017;6:110-118. [PMID: 28446999 DOI: 10.21037/acs.2017.03.18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
311 Deng W, Zhang W, Yang J, Ni W, Yu S, Li C, Chang X, Zhou Z, Chen D, Feng Q, Chen X, Lin Y, Zhu K, Zheng X, He J, Gao S, Xue Q, Mao Y, Cheng G, Sun K, Liu X, Fang D, Chen J, Xiao Z. Nomogram to Predict Overall Survival for Thoracic Esophageal Squamous Cell Carcinoma Patients After Radical Esophagectomy. Ann Surg Oncol 2019;26:2890-8. [DOI: 10.1245/s10434-019-07393-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
312 Mokdad AA, Ali A, Yopp AC, Polanco PM, Nassour I, Mansour JC, Choti MA, Minter RM, Wang SC, Porembka MR. Adoption of evidence-based novel therapies in the treatment of gastric cancer: A national observational study. Cancer 2018;124:1122-31. [PMID: 29211302 DOI: 10.1002/cncr.31179] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
313 Martin JT, Mahan A, Zwischenberger JB, McGrath PC, Tzeng CW. Should gastric cardia cancers be treated with esophagectomy or total gastrectomy? A comprehensive analysis of 4,996 NSQIP/SEER patients. J Am Coll Surg 2015;220:510-20. [PMID: 25667138 DOI: 10.1016/j.jamcollsurg.2014.12.024] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
314 Booker DJ, Whitehead AL. Inside or Outside: Quantifying Extrapolation Across River Networks. Water Resour Res 2018;54:6983-7003. [DOI: 10.1029/2018wr023378] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
315 Paterson S, Duthie F, Stanley AJ. Endoscopic ultrasound-guided elastography in the nodal staging of oesophageal cancer. World J Gastroenterol 2012; 18(9): 889-895 [PMID: 22408347 DOI: 10.3748/wjg.v18.i9.889] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
316 Rice TW, Lerut TE, Orringer MB, Chen LQ, Hofstetter WL, Smithers BM, Rusch VW, van Lanschot J, Chen KN, Davies AR. Worldwide Esophageal Cancer Collaboration: neoadjuvant pathologic staging data. Dis Esophagus. 2016;29:715-723. [PMID: 27731548 DOI: 10.1111/dote.12513] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 7.4] [Reference Citation Analysis]
317 Xu Y, Liu J, Du X, Sun X, Zheng Y, Chen J, Li B, Liu W, Jiang H, Mao W. Prognostic impact of postoperative radiation in patients undergoing radical esophagectomy for pathologic lymph node positive esophageal cancer. Radiat Oncol 2013;8:116. [PMID: 23656920 DOI: 10.1186/1748-717X-8-116] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
318 Akutsu Y, Kato K, Igaki H, Ito Y, Nozaki I, Daiko H, Yano M, Udagawa H, Nakagawa S, Takagi M, Mizusawa J, Kitagawa Y. The Prevalence of Overall and Initial Lymph Node Metastases in Clinical T1N0 Thoracic Esophageal Cancer: From the Results of JCOG0502, a Prospective Multicenter Study. Ann Surg 2016;264:1009-15. [PMID: 27420375 DOI: 10.1097/SLA.0000000000001557] [Cited by in Crossref: 42] [Cited by in F6Publishing: 17] [Article Influence: 8.4] [Reference Citation Analysis]